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ABSTRACT 
Thyroid organogenesis is a very complex developmental process that leads to the 
formation of an organ able to produce specific hormones through specification, migration, 
structural organization and functional differentiation of thyroid precursor cells. In 
mammals, alteration of these mechanisms might be responsible for congenital 
hypothyroidism (CH), the most frequent inherited endocrine disease. 
Thyroid development in fish is comparable to mammals at both ontogenetic and 
molecular levels: the thyroid develops from the endodermal tissue, at the midline of the 
pharyngeal floor, and its formation is subdivided into main successive steps shared with 
mammals. The genetic program involved in fish thyroid differentiation, including the 
activity of transcription factors such as Nkx2.1a, Pax8 and Hhex, is conserved with respect 
to expression patterns and functions.  
To gain further insights on the genetic machinery implicated in normal thyroid 
development, and therefore in CH disease, an oligonucleotide microarray analysis was 
performed in mouse with the aim to identify genes differentially expressed during gland 
organogenesis. This approach highlighted a list of genes enriched in embryonic mouse 
thyroid. In the present work, the zebrafish model was used to perform functional analysis 
on fish counterparts of the murine thyroid enriched genes. Looking at the expression 
territories of the zebrafish orthologs, a very low correlation in thyroid expression profile 
between mouse and zebrafish was found: indeed, very few mouse thyroid expressed genes 
have their zebrafish ortholog being expressed in thyroid primordium. This observation 
strongly suggests that some changes concerning thyroid development occurred from lower 
to higher vertebrates; during evolution, the thyroid of higher vertebrates probably recruited 
new genetic pathways/functions by means of mutations occurred in cis-regulatory 
elements. Despite the low correlation in expression profiles, a new conserved function 
relevant for thyroid development was identified with this comparative approach; an anti-
apoptotic function, represented by Bcl2 in mouse and bcl2l in zebrafish, was conserved 
during thyroid evolution. Knock-down experiments conducted by means of morpholinos 
injection, have revealed that bcl2l is regulated by the thyroid transcription factors and plays 
a relevant role in normal thyroid development. Indeed, bcl2l thyroid expression was lost in 
embryos deprived of the thyroid transcription factors, leading to thyroid degeneration via 
apoptosis. It is feasible to hypothesize that a conserved antiapoptotic function during 
thyroid evolution could counteract a putative proapoptotic function, ready to intervene if 
something fails during normal gland morphogenesis. 
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1. Introduction 
 Organogenesis: the thyroid model 
The development of an embryo is a very complex process that leads to the formation 
of structures, the adult body organs, enormously complicated, and that brings together vast 
numbers of components organized in exactly the right position, assembled in a logistically 
correct time sequence, and connected with the other components to make a functional 
whole. 
In particular, organogenesis in the vertebrate embryos involves 2 processes: 
morphogenesis, which is the shaping of an organ, and cytodifferentiation, which is the 
acquisition and expression of specialized cellular functions within that organ. Both these 
processes require a detailed schedule of cell induction, migration, proliferation, 
differentiation, communication and cell death and are the result of an accurate reading of 
the genetic program. Of course, these steps must be tightly controlled; indeed, an alteration 
at any level of the organogenesis process can lead to a severe impairment of organ function 
and so to an invalidating clinical disorder. 
In line with this, many efforts are being devoted to understand the mechanisms 
involved in organogenesis and therefore in disease, primarily thanks to the study of a few 
model organisms, among which mice and zebrafish. Furthermore, comparative approaches 
are applied to understand how developmental mechanisms have evolved to bring about the 
formation of organs of different shape and function during evolution. 
To study organogenesis the thyroid is a very interesting experimental model. It is an 
endocrine gland present in all vertebrates. It is a rather simple organ, with one main cell 
type, the thyroid follicular cell (TFC) (Gorbman and Bern, 1962); its embryology, 
physiology and pathology are, at least in part, sufficiently known; it is affected by frequent 
diseases, among which congenital hypothyroidism (CH) is the most common congenital 
disorder (1/4000 newborns).  
Thyroid development can be divided into 3 phases in which it is possible to recognize 
the features of organogenetic mechanisms: a)thyroid precursor cell specification, 
b)budding and migration of the thyroid primordium, c)functional differentiation of TCFs.         
The genes and pathways involved in normal thyroid development and function and so 
in disease are at least in part known and this is primarily due to the study of the two most 
used model organisms in developmental biology of vertebrates, mouse and zebrafish. A 
huge amount of knowledge about thyroid development comes from murine models; thanks 
to the researchers ability to generate genetically modified mice, many mouse models for 
thyroid disease are available to the scientific community. In the last years, thanks to the 
studies on the zebrafish thyroid, several novel mechanisms concerning thyroid 
development have been discovered. Moreover the zebrafish has introduced new techniques 
and new strategies to investigate thyroid organogenesis. 
Thyroid gland in mammals 
General aspects 
Thyroid gland in all vertebrates is responsible for producing thyroid hormones (THs). 
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In humans, the thyroid gland is located in front of the trachea and it consists of two 
lobes (Figure 1 A) connected by a central isthmus. It is enveloped by a thin, fibrous capsule 
of connective tissue that sends septa into the gland forming a framework for the entire 
organ. The thyroid parenchyma is composed of various cells. The TFCs, or thyrocytes, 
designed to produce thyroid hormones, are most abundant and are organized in spheroid 
structures known as follicles, each composed of a cell layer surrounding a closed cavity 
containing the colloid, a mixture of proteins, principally thyroglobulin (Tg) (Figure 1 B). 
The follicle may be considered the secretory unit of the organ. In addition to TCFs, 
individual cells or small groups of cells, the C-cells, are distributed among the follicles 
(Figure 1 B). These cells produce calcitonin and derive from the neural crest via the 
ultimobranchial body (UB). In adult human thyroid, they represent 1% of the cell 
population (Wolfe et al., 1974). Outside the follicles two other types of cells populate the 
thyroid, the endothelial cells and fibroblasts. In normal dog thyroid, the relative 
proportions of follicular, endothelial cells and fibroblasts are 70%, 6% and 24% (Dow et 
al., 1986). 
TFCs are highly differentiated cells and express all the proteins required for the 
synthesis and the release of THs, such as Tg (the substrate for synthesis of THs by 
iodination), thyroperoxidase (TPO; the enzyme responsible for Tg iodination), the 
Sodium/Iodide symporter (NIS; that transports iodine into the thyroid cells) (Damante and 
Di Lauro, 1994) and pendrin (PDS; that is responsible for the efflux of iodide from the 
thyroid cell to the follicle’s cavity) (Royaux et al., 2000).  
The main THs are the tetra-idothyronine (T4) or thyroxine, and the triiodothyronine 
(T3). THs production starts with the synthesis of Tg, that is secreted into the colloidal 
lumen of the follicle where it is iodinated on tyrosine residues. After a variable period of 
storage in thyroid follicles, iodinated Tg is subjected to proteolysis and the released 
hormones are secreted into the circulation, where specific binding proteins carry them to 
target tissues (Kirsten, 2000).  
The amounts of T3 and T4 secreted by the thyroid are controlled by the thyroid-
stimulating hormone (TSH) produced by the pituitary gland and the amount of TSH, in 
turn, is regulated by thyroid-
stimulating hormone releasing 
factor (TRF), secreted by the 
hypothalamus. 
The THs are critical in 
regulating the growth and 
differentiation of many tissues 
and organs, as well as energy 
homeostasis and numerous key 
metabolic pathways. THs are 
known to play an important role 
in the perinatal development 
especially of the central nervous 
system (Bernal, 2007). 
Figure 1 Human thyroid gland. (A) Representation of thyroid position 
and related structures in neck region. (B) Cross section of the thyroid 
tissue showing the wall of the thyroid follicle, built from thyrocytes (1), 
the cavity of the thyroid follicle, filled with colloid (2), the blood vessels 
(3)  and parafollicular cells (C-cells) (4). 
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Embryonic thyroid gland development in mammals: morphology 
and genetics 
The thyroid gland development has been exhaustively studied in rodents and, 
because of the high conservation of this process in mammals, it is possible to extend data 
from animal models to humans (see Figure 2 for a timing correlation of relevant events 
during thyroid development in humans and mouse). Indeed, studies on patients affected by 
congenital hypothyroidism with thyroid dysgenesis have confirmed that identical genetic 
mechanisms are involved in thyroid organogenesis both in humans and mice. 
 The thyroid gland development in mammals can be subdivided in few main phases 
characterized by proper morphological and molecular aspects: 
1. Specification of TFC progenitors 
2. Budding of thyroid anlage 
3. Migration of thyroid primordium 
4. Late thyroid morphogenesis and functional differentiation 
These steps are schematized in Figure 2 and the morphology of thyroid during the 
different steps is reported in Figure 4.  
 
Figure 2 Schematic representation of the stages of thyroid gland development and the expression of relevant genes 
(Davies et al., 2005). 
 Specification of TFC progenitors 
After the morphogenetic movement taking place during gastrulation, the definitive 
endoderm is transformed in the primitive gut tube, a cylindrical cavity running along the 
antero-posterior (A-P) axis of the embryo and surrounded by mesoderm. During this 
period, the gut tube regionalizes along the A-P axis into the foregut, midgut and hindgut 
domains. This sub-regionalization is driven by specific networks of signaling molecules 
and transcription factors and is controlled by interactions with nearby mesodermal tissues. 
Specific molecular mechanisms, selectively working in limited domains of the gut tube, are 
responsible also for the specification of the organs precursors (Shivdasani, 2002; Zorn and 
Wells, 2009).  
The thyroid morphogenesis starts with the recruitment of a group of cells at the foregut 
level that enter a “thyroid fate” by means of a definite molecular program. The 
mechanisms responsible for the recruitment and the specification of thyroid precursor cells 
in mouse are largely unknown. Some research papers have reported that mutations of genes 
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expressed in the surrounding tissues and not in thyroid bud itself impair the correct 
organogenesis of the gland (Kameda et al., 2009; Lania et al., 2009; Xu et al., 2002). In 
particular, when Tbx1, an FGF signaling regulator expressed in the nearby thyroid 
mesoderm, is depleted, a smaller number of thyroid precursor cells than normal is 
observed, suggesting a role for this factor in precursors recruitment (Lania et al., 2009).  
In mouse embryo, the thyroid anlage is first visible as a thickening in the primitive 
pharynx at embryonic day (E) 8-8.5 (E20-22 in human) (Kaufman and Bard, 1999). 
Starting from its first appearance, the thyroid anlage is in close spatial relationship with the 
heart primordium. It is reasonable that relevant inductive signals for thyroid specification 
originate from the heart mesoderm. This concept is supported by the findings that: a) 
cardiac malformations represent the most frequent congenital defect associated with 
thyroid dysgenesis (Olivieri et al., 2002); b) concomitant cardiac and thyroid defects have 
been observed in experimental studies (Dentice et al., 2006; Westerlund et al., 2008). 
The precursors of TCFs, since their first appearance in the primitive pharyngeal floor, 
are characterized by the co-expression of four transcription factors: Hhex (Thomas et al., 
1998), Nkx2-1 (Lazzaro et al., 1991), Pax8 (Plachov et al., 1990), and Foxe1 (Zannini et 
al., 1997). Each of these transcription factors is expressed also in other tissues but their 
concomitant expression is a unique hallmark of both differentiated TFCs and their 
precursors (Damante et al., 2001). In Figure 4 A is reported the Nkx2-1 expression in thyroid 
anlage. By means of gene targeting experiments, it was demonstrated that in absence of 
either Nkx2-1, Hhex, Pax8, or Foxe1, thyroid morphogenesis is severely impaired, 
suggesting that each of them plays an essential individual role in gland organogenesis. The 
specific role of these factors in thyroid formation is discussed below.  
 Budding of thyroid anlage 
At E8.5-9 (E24 in human), the thickening deepens forming a small pit and then a 
hollow evagination in the endoderm, called thyroid bud (Romert and Gauguin, 1973) 
Figure 3). During the budding, the thyroid primordium approximates to the distal part of the 
outflow tract of the developing heart (Fagman et al., 2006). 
The molecular mechanisms that regulate thyroid budding are largely unknown. A 
feature of several budding organs is the locally enhanced proliferation of progenitor cells 
(Michael and Davies, 2004). This is not true 
for thyroid primordium in which an 
unexpected low proliferation rate was found 
(Fagman et al., 2006). Lung budding is 
regulated by several factors among which 
Fgf10, secreted by the surrounding 
mesenchyme (Kimura and Deutsch, 2007; Lu 
et al., 2005). It was found that Fgf10 null 
mutant mouse embryos lack both lung and 
thyroid indicating that this secreted protein is 
required for thyroid morphogenesis (Ohuchi 
et al., 2000). However, in this study, only late 
embryos (E18.5) or newborns were analyzed 
precluding any conclusions on the early role 
of Fgf10 in thyroid development. 
 
Figure 3 The thyroid anlage (A) Scanning electron 
micrograph of the ventral wall of the pharynx of an E9 
mouse embryo showing the area where the thyroid bud 
just invaginated, leaving behind the foramen cecum. Pa, 
Pharyngeal arch (De Felice and Di Lauro, 2004). 
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 Migration of thyroid primordium 
The detached bud migrates caudally to reach its final destination at the base of the 
neck, at E13.5 (E50 in human).  
At E10, the migrating thyroid primordium is still connected to the pharyngeal floor by 
a thin channel, the thyroglossal duct (Figure 4 B); a small hole visible at the site of origin in 
the pharyngeal floor (the foramen cecum) is the remnant of the anlage (Figure 3). At E11.5 
the thyroglossal duct disappears, and the thyroid primordium loses all connections with the 
floor of the pharynx and starts to expand laterally. Two days later the thyroid primordium 
reaches the trachea.  
The molecular mechanisms involved in thyroid migration are not completely 
understood. Experiments on mouse models demonstrate that Foxe1 has an important role 
in the migratory process. Indeed, in Foxe1 mutant mouse embryos the thyroid is either 
absent or attached to the pharyngeal endoderm (De Felice et al., 1998).  
A still open debate is whether embryonic thyroid migration is an active process due to 
a cell-autonomous mechanism or it is a passive process consequent to other morphogenetic 
events occurring in the neck region (Fagman and Nilsson). A characteristic of active 
migrating cells is the epithelial-mesenchymal transition (EMT): the migrating cells lose 
their epithelial phenotype and acquire mesenchymal features; they also acquire a spindle-
shaped morphology (Thiery and Sleeman, 2006). However, TFC precursors seem to use a 
different and yet unidentified pathway to move, because the EMT is not observed and the 
cells retain their epithelial phenotype (Fagman et al., 2003). One recent finding, the so 
called collective cell migration, implicates that firm cell-to-cell adhesion, as it is observed 
in migrating thyroid, is a prerequisite for the movement of groups of cells (Friedl and 
Gilmour, 2009). This new mechanism could fit with thyroid translocation, considering also 
that the thyroid primordium has a leading edge that points toward the migration direction 
(Fagman et al., 2006), another feature observed in the collective migration.  
 Late thyroid morphogenesis and functional differentiation  
When the thyroid primordium reaches its final position, in front of trachea (E13-5, 
E14), also the fusion with the UB 
occurs (Cordier and Haumont, 1980). 
At this point, the gland acquires its 
final shape and the lobes expand 
considerably (E15-16). The 
mechanisms underlying the 
proliferation of the precursors and the 
formation of the lobes are unknown. 
Surprisingly, while TSH is an 
important growth stimulus for adult 
thyroid cells, it is not relevant for the 
proliferation of the fetal thyroid cells 
(Marians et al., 2002; Postiglione et 
al., 2002). Genetic studies in mouse 
support a morphogenetic role for the 
embryonic vascular anatomy in late 
thyroid development; when either 
Sonic hedgehog (Shh) (Fagman et al., 
2004) or Tbx1 (Fagman et al., 2007) 
Figure 4 Thyroid morphology in mouse embryo (A-E) Cross 
sections stained for Nkx2.1 antibody. (A) Thyroid anlage at E9.5. 
(B) Thyroid primordium at E10.5. (C) Thyroid primordium at 
E12.5. (D) Thyroid at E15.5. a, Aorta; as, aortic sac; e, foregut 
endoderm; m, mandibular component of first branchial arch; p, 
pharynx; th, thyroid primordium (Fagman et al., 2003). 
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activity is disrupted, correct patterning of the vessels is disturbed. In these conditions also 
the lobulation process is impaired and the thyroid assumes the shape of a midline mass 
located lateral to the trachea. 
In the mouse, the first small thyroid follicles begin to appear by E15.5 (Figure 4 D) 
(E70 in human) and a day later the gland displays the typical follicular organization. At 
this point, the thyroid primordium is a functional gland able to produce and release 
hormones, by means of the expression of genes required for thyroid function.  
 
The hallmark of the thyroid cells  
The small number of cells in the pharyngeal floor which are fated to become TFCs are 
univocally characterized by the co-expression of Nkx2-1, Foxe1, Hhex and Pax8 already at 
E8.5. The simultaneous expression of these factors is a hallmark of the thyrocite during its 
embryonic and adult life; although each of these proteins are also present in other 
embryonic tissues, where they exert distinct roles, only in thyroid they work together to 
drive organogenesis. These transcription factors were identified by virtue of their binding 
to the promoter of genes whose products are markers of terminal differentiation of thyroid 
follicular cells. It is worth noting that, 
in thyroid cells, they form a network 
of reciprocal cross-interactions (Figure 
5). From in vitro studies we know that 
Pax8 and Nkx2-1 interact physically 
(Di Palma et al., 2003); binding sites 
for Nkx2-1 and Pax8 were found in 
the Hhex promoter and it was 
demonstrated that these two factors are 
able to regulate the transcriptional 
activity of Hhex promoter (Puppin et 
al., 2003; Puppin et al., 2004); Pax8 
activates the transcription of Foxe1 
(D'Andrea et al., 2006); in addition, 
Hhex and Nkx2-1 autoregulate their 
own promoters (D'Andrea et al., 2006; 
Puppin et al., 2003). In vivo studies 
have confirmed these findings even if 
the transcriptional regulation appears 
to change as the primordium 
progresses from one to the following 
developmental stage (Parlato et al., 
2004). Indeed, at E8.5, when either 
one of Nkx2-1, Pax8 or Hhex is deleted, the expression of the other two transcription 
factors remains unaltered; only Foxe1 is under the control of Pax8 already at this stage 
(Parlato et al., 2004). However, in the successive developmental steps the expression of 
Pax8 and Foxe1 is lost in Hhex null embryos and both Foxe1 and Hhex are down-regulated 
in Nkx2-1 or Pax8 deficient embryos (Parlato et al., 2004). Foxe1 probably holds a lower 
position in this network since the expression of the other transcription factors is maintained 
in Foxe1-deficient progenitors (De Felice et al., 1998; Parlato et al., 2004). 
Figure 5  Functional interaction among Hhex, Nk2-1, Pax8 and 
Foxe1 in developing thyroid. The transcription factor and the 
functions controlled by it are indicated in different colors. Each 
factor regulates other transcription factors controlling the onset 
(arrow) or the maintenance (square) of their expression (Parlato 
et al., 2004). 
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Genes involved in thyroid morphogenesis  
The expression of the four transcription factors at the very beginning of thyroid 
morphogenesis suggested that these genes might play an important role in the process. This 
hypothesis has been confirmed by studies on animal models. Mice deficient for Nkx2.1 
(Kimura et al., 1996; Kimura et al., 1999), Hhex (Martinez Barbera et al., 2000), Pax8 
(Mansouri et al., 1998) or Foxe1 (De Felice et al., 1998) are well-studied models of 
athyreosis (absence of thyroid gland). In these embryos the thyroid bud is correctly formed 
but eventually disappears leading to lack of thyroid tissue in late developmental stages. 
These findings indicate that Nkx2.1a, Hhex, Pax8 and Foxe1 are required for the survival 
and growth of thyroid progenitors but are not necessary for thyroid specification and early 
bud formation. However, the presence of these genes is not sufficient to guarantee a correct 
organogenesis of the gland. Mutations in other genes too, both thyroid-enriched and 
ubiquitous, have been demonstrated to impair the thyroid development. 
Nkx2.1a 
Nkx2.1a is a 42 kDa homeodomain-containing transcription factor (Guazzi et al., 
1990) expressed in both differentiated TFCs and in their precursors; in the thyroid 
primordium it is detected as soon as the thyroid anlage is visible. Nkx2-1 was found also in 
the trachea and lung epithelium and in some areas of forebrain, including the posterior 
pituitary (Lazzaro et al., 1991). In thyroid gland, Nkx2-1 expression is not restricted to the 
follicular cells; it is also present in parafollicular C-cells (Suzuki et al., 1998) and it was 
found in the epithelial cells of the UB (Mansouri et al., 1998).  
In absence of Nkx2-1, mice die at birth because of pulmonary dysplasia. The thyroid 
defect is also severe; the anlage forms in its correct position but by E10.5 it appears 
smaller in size in comparison to wild type and subsequently undergoes degeneration (Figure 
6). In these mutants also the pituitary is absent and severe alterations in the ventral region 
of the forebrain are observed (Kimura et al., 1996; Kimura et al., 1999).  
The presence of the thyroid bud in mutant mouse embryos has demonstrated that 
Nkx2-1 is dispensable for the initial commitment of thyroid cells, but the late thyroid 
phenotype has established that this transcription factor is required for the survival and 
differentiation of the cells. The mechanism by which the thyroid primordium degenerates 
in the absence of Nkx2-1 has not been investigated in detail. The presence of fragmented 
nuclei in Nkx2-1 deficient progenitor cells suggests involvement of an apoptotic process 
(Kimura et al., 1999). In support of this possibility an increased number of TUNEL 
positive cells is observed in the Nkx2-1-deficient UB (Kusakabe et al., 2006). 
The mechanisms responsible for the 
thyroid expression of Nkx2-1 are not 
clear. The expression of Nkx2-1 in the 
forebrain is Shh-dependent: indeed, in 
Shh-deficient mouse no Nkx2-1 is 
observed in the brain, whereas normal 
levels of the protein are detected in the 
thyroid and lung anlage (Pabst et al., 
2000). In vitro studies have proposed 
that the Gata6 factor regulates the 
transcription of Nkx2-1 (Shaw-White 
et al., 1999). However, analysis of 
Gata6
-/-
lungs has demonstrated that 
Figure 6 Nkx2.1 is responsible for thyroid development. Cross 
sections of wild-type (A) and Nkx2-1
-/-
 (B) E12-13 mouse 
embryos. The thyroid is absent in the mutant embryo. (Thr) 
Thyroid; (Tp) thymic primordium; (Tr) trachea (Kimura et al., 
1996). 
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Nkx2-1 is normally localized in epithelial cells of both wild-type and mutated lung 
(Keijzer et al., 2001).  
Another issue that remains to be explored is the identification of the genes controlled 
by this transcription factor in the thyroid primordium. A detailed analysis of the phenotype 
of the affected tissue reveals that in absence of Nkx2-1, the expression of Bmp4 (Minoo et 
al., 1999) and Fgf8 (Takuma et al., 1998) is abolished in the developing lung and in the 
posterior pituitary, respectively. These data indicate that signaling molecules relevant for 
the morphogenesis of embryonic structures are controlled by this transcription factor. The 
finding that Fgfr2 is expressed in the thyroid bud, suggests that Nkx2-1 could regulate the 
survival of TFCs through an Fgf-dependent mechanism (Parlato et al., 1999). 
In differentiated thyroid cells, Nkx2-1 controls the expression of thyroid-specific 
genes, Tg and Tpo (De Felice et al., 1995), Nis (Endo et al., 1997) and Tshr (Civitareale et 
al., 1993).   
Orthologs of Nkx2-1 have been found in chicken (Pera and Kessel, 1998), frog (Small 
et al., 2000) and zebrafish (Rohr and Concha, 2000), where the distribution of Nkx2-1 is 
similar to that of mouse. The expression of Nkx2-1 in the ascidian Ciona intestinalis 
(Urochordata, Chordata) (Ristoratore et al., 1999) is really interesting: Nkx2-1 mRNA is 
present in some areas of the adult endostyle, the homolog of the vertebrate thyroid gland,  
but not in the same cells that concentrate iodine and express a peroxidase similar to Tpo. 
Hence, it could be speculated that the primordial function of Nkx2-1 was to specify the 
most anterior part of the gut and not to control the expression of genes involved in thyroid 
function. Nkx2-1 could have acquired this function later during the chordate evolution (De 
Felice and Di Lauro, 2004). 
 Pax8 
Pax8 is a transcription factor containing a paired domain acting as a DNA binding 
domain. Within the Pax gene family, Pax8 forms a subfamily with Pax2 and Pax5 on the 
basis of sequence similarity. Pax8, like Nkx2-1, is expressed in adult and developing 
thyroid since the early stages of gland morphogenesis but it is not expressed in the UB. In 
addition, Pax8 is transiently expressed in the early developing myelencephalon and 
throughout the embryonic life of the neural tube; it is also present in the developing 
kidney, where it is expressed throughout adult life (Plachov et al., 1990). 
Pax8
-/-
 mice which are born at the expected Mendelian ratio but with a low body 
weight, die within three weeks because of hypothyroidism (Friedrichsen et al., 2003; 
Mansouri et al., 1998). In contrast to the previously described knock-out mouse, Pax8
-/- 
newborns have a restricted phenotype: TFCs are completely absent, but C-cells are normal 
(Figure 7). The animals present a rudimental gland composed almost completely of 
calcitonin-producing C cells and there is no other malformation. Moreover, the thyroid 
anlage forms, evaginates from the endoderm and begins to migrate. However by E11 the 
thyroid bud is smaller in comparison to that of wild type (Mansouri et al., 1998). Finally by 
E12.5 TFCs are not detectable (Mansouri et al., 1998). Thus, like Nkx2-1, Pax8 seems to 
be involved in TFC survival rather than in specification. The precise mechanism leading to 
the thyroid phenotype in these animals is unknown but it may involve loss of cells by 
apoptosis. A protective role of Pax genes against apoptosis has been suggested by in vitro 
studies on tumour cells (Bernasconi et al., 1996; Muratovska et al., 2003) and confirmed 
by in vivo studies on C.elegans in which the two Pax2/5/8 genes act promoting cell 
survival (Park et al., 2006).  
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It is worth noting that other transcription factors, such as Foxe1 and Hhex, are down-
regulated in the precursors of thyroid cells in the absence of Pax8 (Parlato et al., 2004). 
This observation demonstrated that Pax8 is not only required for the survival of thyroid 
precursor cells, but also holds an upper role in the genetic regulatory cascade controlling 
thyroid development. 
 
Figure 7 Pax8 is responsible for TCFs survival. Cross sections of wild-type (A, B, C, D) and Pax8-/- (E, F, G, H) 
E18.5 mouse embryos stained with an Nkx2-1 (A, E) or Tpo (D, H) probe by in situ hybridization and with Tg (B, F) or 
calcitonin (C, G) antibody by immunohistochemistry. The small thyroid observed in the mutant mice is composed 
exclusively by C-cells as demonstrated by the positivity of these cells for Nkx2-1 and Calc and not for Tg and TPO that 
are absolutely TCFs markers. Black arrows in (E) indicate calcitonin positive cells (Mansouri et al., 1998). 
It has been demonstrated that Pax8 is the master gene for the regulation of thyroid-
differentiated phenotype (Pasca di Magliano et al., 2000). It is able to bind and to activate 
the promoters of Tg and Tpo (Pasca di Magliano et al., 2000; Zannini et al., 1992) and an 
enhancer of Nis (Ohno et al., 1999). Using de-differentiated tumour thyroid cells, it was 
shown that Pax8 is able to induce a re-differentiation of these cells (Presta et al., 2005).  
Very little is known about the transcriptional regulation of Pax8. The first thyroid-
transcriptional regulatory element of the Pax8 gene has been only recently identified; this 
element has the features of an enhancer and contains two binding sites for Nkx2-1, 
suggesting that this transcription factor participates to Pax8 expression (Nitsch et al.). This 
finding is supported also by the slightly reduced expression of Pax8 observed in Nkx2-1
-/-
 
mice (Parlato et al., 2004). 
 Foxe1 
Foxe1 is a 42 kDa winged helix/forkhead transcription factor. Like Nkx2-1 and Pax8, 
Foxe1 is detected in the thyroid primordium since E8.5 but its expression is extended to all 
endodermal cells of the foregut floor. The thyroid-specific expression is maintained during 
all developmental stages and in adulthood. During early embryonic life, Foxe1 is detected 
also in the pharyngeal arches and transiently in the Rathke's pouch. Subsequently, it is 
expressed in the tongue, palate, epiglottis, esophagus, and in the whiskers and hair follicles 
(Dathan et al., 2002).  
Foxe1 deficient mice are born at the expected Mendelian ratio but die within 48 hours, 
probably due to the severe cleft palate observed. The thyroid phenotype is rather complex: 
the formation of thyroid bud occurs normally but its fate is variable (Figure 8). Indeed, at 
E10 the thyroid is no more present in 50% of the embryos (Figure 8 C), whereas TFCs are 
observed but they are still on the floor of the pharynx in the remainder cases (Figure 8 B). At 
the later stages of development, mutant mice continue to exhibit either a small thyroid 
remnant, still attached to the pharyngeal floor, or no thyroid gland at all (De Felice et al., 
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1998; Parlato et al., 2004). These data indicate that Foxe1 has an essential role in 
promoting thyroid bud migration but it is not involved in thyroid specification and 
budding. The mutant mice that completely lose the thyroid tissue indicate that Foxe1 is 
also involved in thyroid cells survival. In any case, it is not involved in TFCs 
differentiation because the non-migrating thyroid cells are able to produce Tg. At the 
moment, the genes that execute the migration program controlled by Foxe1 are still 
unknown. In addition, the variable phenotype observed in Foxe1
-/- 
mice illustrates that, 
from a common genetic lesion, additional genetic or stochastic events can modulate 
thyroid development.  
Little is known about the regulation of Foxe1. In absence of Pax8, Foxe1 is not 
detected in TFC precursors (Parlato et al., 2004) consistent with the presence of Pax8 
binding sites in the Foxe1 5’ UTR (D'Andrea et al., 2006). 
In the adult gland, the role of Foxe1 is not yet clear. In vitro functional studies in rat 
thyroid cells have shown that Foxe1 can act as a promoter-specific transcriptional repressor 
(Perrone et al., 2000).  
 
Figure 8 Foxe1 is important for thyroid bud migration. Sagittal sections of E11.5 Foxe1
+/- 
(A) and Foxe1
-/-
 (B-C) 
mouse embryos stained with an anti-Nkx2-1 antibody. In mutant embryos, the thyroid primordium is either present 
but still attached to the pharyngeal floor as shown in B, or absent as shown in C. Ph, pharynx; Th, thyroid bud; Ao, 
aorta; Tr, trachea (De Felice et al., 1998). 
Until now, Foxe1 homologous genes have been identified in a few species. 
Phylogenetic analysis suggests that the ancestral precursor of the vertebrate thyroid-
specific Foxe1 is a FoxE4-like gene expressed in lens and pharynx. In the urochordate C. 
intestinalis, Ci-FoxE is expressed in the adult endostyle and is detected in the same cells 
that express Ciona TPO (Ogasawara and Satou, 2003). Interestingly, a gene homologous of 
FoxE4, AmphiFoxE4, was isolated from the amphioxus (Cephalochordata, Chordata) (Yu 
et al., 2002); the expression of AmphiFoxE4 does not occur in the endostyle but in the 
club-shaped gland, a pharyngeal-derived structure located near the endostyle that has no 
obvious homology with any vertebrate structures. It was proposed that the expression of 
FoxE4 was transferred from the homolog of the club-shaped gland to the endostyle during 
the rise of vertebrates (Mazet, 2002). 
  Hhex 
Hhex is a transcription factor characterized by a homeodomain as a DNA binding 
domain (Bedford et al., 1993; Crompton et al., 1992). During mouse development, it is 
expressed in the primitive endoderm and then in the definitive endoderm. At later stage, 
Hhex mRNA can be detected in the ventral gut and finally, from E8.5, in the primordium 
of many organs derived from the foregut, such as thyroid, thymus, liver, pancreas and 
lungs. Thyroid expression of Hhex is maintained until adulthood (Bogue et al., 2000; 
Thomas et al., 1998). 
The analysis of Hhex 
-/- 
embryos has revealed that this factor is absolutely necessary 
for thyroid morphogenesis (Martinez Barbera et al., 2000). Hhex null mice show multiple 
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malformations and are no more viable after E15.5. Thyroid specification occurs in Hhex 
mutants where the thyroid anlage is normally present at E9 but becomes absent or severely 
hypoplastic one day later, suggesting that Hhex, as well as Nkx2-1, Pax8 and Foxe1, is not 
required for thyroid specification (Parlato et al., 2004). Concurring with the morphological 
alteration is the strong reduction in Nkx2.1, Pax8 and Foxe1 levels in the mutant mice 
(Figure 9); the role of Hhex could then be to maintain the expression of these transcription 
factors in thyroid cells (Parlato et al., 2004). 
Some reports have indicated that Hhex can work as a transcriptional repressor 
(Brickman et al., 2000; Ho et al., 1999; Noy et al.) and that in thyroid cell lines it is able to 
inhibit Tg promoter activity (Pellizzari et al., 2000). 
About Hhex regulation, cell culture studies have demonstrated that both Nkx2-1 and 
Hhex itself (Puppin et al., 2003), as well as Pax8 (Puppin et al., 2004), are able to activate 
the Hhex promoter. 
 
Figure 9 Hhex is important for thyroid development. Cross sections of wild- ype (A,B,C) and Hhex
-/-
 (D,E,F) E10 
mouse embryo stained with anti-Nkx2-1  (A,D), anti-Pax8 (B,E) and anti-Foxe1 (C,F) specific antibodies. At E10 the 
thyroid primordium is hypoplastic (D) and both Pax8 (E) and Foxe1 (F) are strongly downregulated in the thyroid 
rudiment (encircled); Foxe1 expression in the endodermal cells of the pharynx is preserved (L, arrowheads). p, 
pharynx; th, thyroid (Parlato et al., 2004). 
Congenital hypothyroidism with thyroid dysgenesis 
Description and genetics 
Congenital hypothyroidism (CH) is defined as thyroid hormone deficiency present at 
birth; it is the most common congenital endocrine disorder (Toublanc, 1992) with the 
incidence varying considerably with geographic location (Rastogi and LaFranchi).  
Patients with CH can be divided mainly into two groups: those with inborn errors of 
thyroid hormone biosynthesis (dyshormonogenesis, TDH) (15% of cases) and those with 
thyroid developmental defects (dysgenesis, TD) (85% of the cases) (Grant et al., 1992). 
Mutations associated with TDH have been found in almost all the genes coding for the 
proteins responsible for THs synthesis (Abramowicz et al., 1992; Everett et al., 1997; 
Medeiros-Neto et al., 1993; Moreno et al., 2002; Moreno et al., 2008; Pohlenz et al., 1997). 
TD constitutes a heterogeneous group of affections due to disturbances in the gland 
organogenesis. It presents three major forms: thyroid ectopy, athyreosis or agenesis, and 
thyroid hypoplasia. 
 Ectopic thyroid means that the thyroid gland is not located in the right position and 
probably it is a consequence of thyroid migration defects. More than 50% of patients 
affected by CH shows an ectopic thyroid (Castanet et al., 2001), but, up to now, no 
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mutations in known genes has been associated to this dysgenesis, including FOXE1 whose 
murine ortholog is known to control thyroid migration. 
 Thyroid agenesis or athyreosis account for 20-40% of CH cases. Both athyreosis and 
agenesis indicate the complete lack of thyroid tissue. However, agenesis means a total 
absence of the gland due to a defective initiation of thyroid morphogenesis. The term 
athyreosis indicates a dysgenesis characterized by the disappearance of the thyroid due to 
alterations in any step following the specification of the thyroid anlage. Up to now, there 
are no mouse model for thyroid agenesis because the initial specification always occurs in 
the models studied. Genes involved in early regionalization of the endoderm as well as 
genes responsible for the expression of NKX2-1, FOXE1, PAX8 and HHEX  in the thyroid 
bud could be affected in the cases of thyroid agenesis. On the contrary, all knock-out mice 
described in the previous section seem good models of athyreosis. Up to now, FOXE1 is 
the only gene in which mutations associated with athyreosis have been identified 
(Bamforth et al., 1989; Castanet et al., 2002; Clifton-Bligh et al., 1998). 
Hypoplastic thyroid means a gland smaller than normal. Hypoplastic thyroid is 
reported in 5% of CH cases. It could be a consequence of alterations in any of the steps 
controlling the number of thyroid cells during organogenesis. The best candidate gene for 
the control of adult thyroid growth is TSHR; indeed, loss-of-function mutations in this gene 
have been reported in patients with thyroid hypoplasia (Alberti et al., 2002; Cangul et al., ; 
Castanet et al., 2002; Clifton-Bligh et al., 1998; Jeziorowska et al., 2006; Nagashima et al., 
2001; Park et al., 2004; Sunthornthepvarakui et al., 1995; Tonacchera et al., 2001). 
Heterozygous mutations in NKX2-1 and PAX8 have been reported in patients with variable 
grade of CH ranging from mild to severe hypoplasia, also in the presence of the same 
mutation, suggesting that the genetic background plays an important role in the appearance 
of NKX2-1 or PAX8 defects (Carre et al., 2009; Congdon et al., 2001; de Sanctis et al., 
2004; Doyle et al., 2004; Grasberger et al., 2005; Krude et al., 2002; Macchia et al., 1998; 
Moya et al., 2006; Nagasaki et al., 2008).    
Thyroid hemiagenesis has been included in the group of TD (Maiorana et al., 2003). 
This term is referred to the condition in which only one lobe is present. Thyroid 
hemiagenesis has a prevalence of 0.2-0.05% in normal population (Maiorana et al., 2003). 
The exact genetic mechanisms that are impaired in thyroid hemiagenesis are still unknown. 
Interestingly, it has been reported that adult double-heterozygous for both Nkx2-1 and 
Pax8-null mutations mice show a high incidence of thyroid hemiagenesis, suggesting the 
genetic origin of this condition (Amendola et al., 2005).  
The finding that TD is, at least in a subset of the patients (so far in less than 5%), 
caused by molecular genetic defects, which in principle are inheritable and that take place 
in genes accountable for TD also in animal models is the strongest argument supporting the 
notion of TD as a genetic and heritable disease. Of course the report of different thyroid 
phenotypes associated with the same genetic defect or the discordance for TD observed in 
monozygotic twins (Perry et al., 2002) are index that TD can range from monogenic to 
multifactorial genetic etiologies and that environmental and epigenetic modifiers are likely 
to be contributing factors.   
Zebrafish advantages to study vertebrate organogenesis 
The zebrafish (Danio rerio), a member of the Cyprinidae group of teleosts, is a 
tropical freshwater fish, native of India and Burma. It is one of the most important 
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vertebrate model organisms for biological research because of a combination of excellent 
embryology and powerful genetic manipulation. The excellent embryology is due to 
different aspects: a)fertilization and embryonic development are external and occur in large 
clutches; b) developing embryo is transparent, aiding observation of organogenic processes 
in live as well as embryonic manipulations, such as single cell injection with tracer dyes in 
intact developing embryos to track emerging cell lineages, the ablation of specific cells, the 
individual cell transplantation; c) embryonic development is very rapid, at 24 hours post 
fertilization (hpf) all the vertebrate body features can be seen, all organ primordial are in 
place and start to mature. Furthermore, despite an evolutionary distance of about 370 M 
years between mammals and teleosts, the molecular mechanisms underlying organs 
development are highly conserved giving the opportunity to use the zebrafish as a model to 
study organogenesis and as a complementary tool for the investigation of human diseases 
(this fish is able to phenocopy many genetic syndromes). The zebrafish organs can be 
considered as a minimalistic version of those of higher vertebrates, allowing also easier 
studies: indeed, using a much lower number of cells they execute the equivalent function in 
the organism. 
The powers of genetic manipulation in this model are associated with the zebrafish 
genome-sequencing project started in 2001 at the Wellcome Trust Sanger Institute 
(http://www.sanger.ac.uk/Projects/D_rerio/) and, to date, almost completed. The analysis 
of the zebrafish genome has revealed an extensive coding sequence conservation with 
higher vertebrates that enables relatively efficient delineation of the cognate orthologs for 
comparative biology (Postlethwait et al., 2000). The first crucial advantage of zebrafish 
associated to genome sequencing was the possibility to identify gene functions by means 
of mutagenesis screenings. Other techniques largely used for gene manipulation are a) the 
generation of transgenic fish lines that allow the stable expression of specific gene product, 
b) RNA injection to study gene’s gain-of-function activity and c) gene knockdown by 
morpholino (MO) injection to study gene’s loss-of- function. 
A feature of the zebrafish genome is the presence of many duplicate copies, or co-
orthologs, of single copy human genes. Many observations suggest that the mechanism 
underlying zebrafish duplicated genes is a whole genome duplication happened during the 
early evolution of the teleost fish lineage (Taylor et al., 2001). After genome duplication, 
the duplicated chromosomes began to rearrange and to lose duplicate genes, possibly due 
to functional redundancy. However, there are also retained duplicate genes (the rate of 
duplicated genes retentions is estimated in the realm of 20-30%) (Woods et al., 2005), 
some of which have the ancestral function divided between the two copies 
(subfunctionalisation) and some with new functions (neofunctionalisation) (Wagner, 
1998).  
 Zebrafish embryology 
A complete and detailed description of zebrafish embryonic development is reported 
in (Kimmel et al., 1995). Embryonic staging of zebrafish is based upon morphological 
criteria. Each stage corresponds to a specific time of incubation at 28.5°C (the zebrafish 
optimal temperature of development) after eggs fertilization. Zebrafish development is 
divided in successive periods. The zygote period starts with the egg fertilization and lasts 
for around 40 minutes. The zygote is subdivided into two visibly different parts: a clear 
blastodisc at the animal pole and a yolky cytoplasm at the vegetal pole ( Figure 10 A). The 
blastodisc undergoes cleavage and gives rise to blastomeres, the cells that later form the 
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embryo during the cleavage period (3/4 - 2 ¼ hpf). At the end of the cleavage period, the 
64-cell blastomeres form a mound of cells on top of the large yolk ( Figure 10 B). In the 
following period, the blastula period (2 ¼ - 5 ¼ hpf) ( Figure 10 C-D), epiboly begins. 
Epiboly describes the thinning and spreading of the cellular blastodisc over the yolk. The 
blastula period ends at the 30% epiboly (30% epi) stage, when all blastomeres cover 30% 
of yolk surface ( Figure 10 D). Epiboly continues during the gastrula period (5¼ - 10 h) ( 
Figure 10 E), when also the morphogenetic cell movements of involution, convergence and 
extension occur, producing the primary germ layers (ectoderm, mesoderm and endoderm) 
and the embryonic axes. Thus, the anterior head of the embryo is clearly distinguished 
from the posterior tail bud, dorsal tissues are distinct from ventral ones and medial tissues 
are easily discernible from lateral ones ( Figure 10 F). Finally, near the end of the gastrula 
period, the neural plate is formed, which is the first morphological sign of the development 
of central nervous system. 
 
Figure 10 Zebrafish developmental stages. The animal pole is to the top for the early stages (A-E), anterior is up (F) or 
to the left (G-L) at later stages (Modified from Kimmel et al., 1995). 
The embryo elongates considerably during the segmentation period (10 - 24 hpf) 
when a variety of morphogenetic events occur ( Figure 10 F-G). A full complement of about 
30 bilateral somite pairs forms in an anterior to posterior sequence. The rudiments of 
primary organs, become visible. The neural tube is formed and the brain becomes 
regionalized, with the forebrain, midbrain and hindbrain becoming distinct from one 
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another. The first weak muscular contractions happen. At 24 hpf, somitogenesis is 
complete and the embryo possesses a beating heart and circulating blood. 
During the pharyngula period (24-48 hpf) ( Figure 10 H-I), the seven pharyngeal arches 
are rapidly formed, the head straightens, pectoral fins appear, pigment cells differentiate, 
the circulatory system is formed, and coordinated swimming movements begin. By the end 
of this period, morphogenesis of many organ rudiments is rather complete, except for the 
gut and its associated organs.  
During the hatching period (48-72 h), embryos develop branchial arches, mouth and 
they complete development of most organs ( Figure 10 L). Embryogenesis ends at 72 hpf 
with the formation of the first fish bone, the cleithrum. After the hatching period, animals 
are called larvae. After the hatching period juvenile zebrafish starts swimming and feeding. 
The zebrafish embryo rapidly becomes a small version of the adult.  
Thyroid gland in zebrafish 
General aspects 
As in other vertebrates, the functional unit of the teleost thyroid is the follicle, which is 
composed of endoderm-derived thyrocytes, it is filled with colloid, and seems to produce 
thyroid hormones in the same way. Follicular cells in zebrafish thyroid resemble 
thyrocytes of higher vertebrates in all aspects: they express the orthologous transcription 
factors nk2-1a (Rohr and Concha, 2000), pax2.1, pax8 and hhex (Wendl et al., 2002) 
necessary for thyroid differentiation, the orthologous proteins involved in thyroid hormone 
synthesis such as slc5a5 (also known as Nis) and cathepsin b (a protease involved in the 
proteolytic cleavage of iodinated TG) (Alt et al., 2006b); they produce TG (Alt et al., 
2006b), accumulate iodine (Elsalini et al., 2003) and synthesise T4 (Wendl et al., 2002). It 
is interesting to observe that, in zebrafish, another Pax family gene, pax2a, is expressed in 
thyroid, besides pax8.  
In contrast to higher 
vertebrate, however, the gross 
thyroid morphology of many 
teleosts is really different; in 
particular, the adult zebrafish 
thyroid consists of follicles 
that are not encapsulated by 
connective tissue to form a 
compact single gland, but that 
lie individually between the 
first gill arch and the bulbus 
arteriosus along the ventral 
aorta, within the mesenchyme 
of the ventral head region 
(Figure 11) (Wendl et al., 
2002). Another difference with mammals concerns C-cells localization. In zebrafish larvae, 
calcitonin-producing cells were found adjacent to the muscle surrounding the gut, far away 
from the thyroid follicles (Alt et al., 2006b). 
Figure 11 (A) Reconstruction of the distribution of thyroid follicles in the 
adult zebrafish head. Thyroid follicles in blue, heart and ventral aorta in 
red, gill arches in yellow. (B) Schematic drawing of a zebrafish larval head 
of 4.5 to 6 days post fertilization (dpf), ventral view, showing the skeleton, 
parts of the circulatory system and the thyroid. Blue, thyroid; brown, third 
to sixth branchial arches; green, basibranchial cartilage; magenta, second 
branchial arch; orange, heart and ventral aorta; yellow, first branchial 
arch. ch, ceratohyal cartilages; h, heart; me, Meckel’s cartilage; pq, 
palatoquadrate; va, ventral aorta. 
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Embryonic thyroid development in zebrafish 
Despite some morphological differences, the mechanisms underlying thyroid 
development are conserved between mouse and zebrafish. The studies carried out on 
zebrafish have confirmed for the most part what had already been found in mammals and 
have given new insights about thyroid gland development. In the following description I 
will focus on the knowledge about thyroid development acquired working with zebrafish 
as a model system. 
 
Figure 12 Schematic illustration of thyroid development in zebrafish. The scale bar shows time of development 
(h, hpf). (a) Early marker gene expression in endoderm; (b) primordium budding at ventral midline of pharynx; (c, d) 
evagination and migration; (e) differentiation into one first follicle; (f) growth of follicles. Yellow arrows indicate the 
timing of thyroid genes expression; orange arrow the growth phase of thyroid development; red arrow onset of 
thyroid function as judged by T4 production (Elsalini et al., 2003). 
Also in zebrafish the thyroid development is classically subdivided into few 
distinguishable steps (Figure 12), shared with mammals: a) specification of TFC 
progenitors; b) budding of thyroid anlage; c) migration of thyroid primordium; d) late 
thyroid morphogenesis and functional differentiation of thyroid follicles. 
Like in mammals, the zebrafish thyroid develops from the endodermal tissue at the 
level of the pharyngeal floor. The first direct proof that thyroid embryonic progenitor cells 
are completely derived from the definitive endoderm was obtained by means of a fate-
mapping experiment conducted in zebrafish embryo, the first one for thyroid in any species 
(Alt et al., 2006b). In this study, to test whether the thyroid derives from Nodal-dependent 
endoderm, ectopic Tar* expression was used. Injection of Tar* mRNA causes activation of 
Nodal/activin pathway and induces zebrafish injected blastomeres to become endoderm in 
a cell-autonomous manner (David and Rosa, 2001). Alt and colleagues observed that 
injecting Tar
*
 mRNA together with a lineage tracer, all thyroid primordium cells expressed 
this tracer indicating that they derived from the injected cell. These data confirmed that the 
midline primordium of the thyroid derives from Nodal-dependent endoderm. The 
endodermal origin of thyroid is also confirmed by its absence in zebrafish mutants of the 
Nodal cofactor one-eyed-pinhead (oep) in which the endoderm is not specified and the gut 
tube fails to form (Elsalini et al., 2003). The thyroid anlage is also completely absent in 
cas
-/-
 and bon
-/-
 mutants (Elsalini et al., 2003), in which activation of Sox17, a downstream 
effector of Nodal crucial for the expression of endoderm specific genes, is disrupted. The 
demonstration that this phenotype, in addition to be secondary to the global disturbance of 
endoderm formation, is also thyroid-specific, come from the finding that in zebrafish 
mutants of the GATA homologue faust (fau), a downstream target of Nodal that activates 
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Sox17, thyroid primordium is lost (Elsalini et al., 2003) whereas at the same time early gut 
tube formation is only mildly affected (Reiter et al., 2001). 
In zebrafish, the specified thyroid precursor cells appear at 24 hpf, characterized by 
co-expression of key transcription factors such as hhex, nk2.1a, pax2a and pax8 ( Figure 13 
A). Elsalini and colleagues have demonstrated that during differentiation of the thyroid 
gland, zebrafish hhex, nk2.1a, and pax2a act presumably in the same manner as mouse 
Hhex, Nkx2.1 and Pax8, respectively. Knock-down experiments have demonstrated that in 
zebrafish these genes have a late role in thyroid development and are not involved in early 
thyroid specification; when one of these transcription factors is absent, the expression of 
molecular markers is lost and the thyroid primordium disappears (in  Figure 13 B is reported 
the downregulation of nk2.1a using a specific morpholino) (Elsalini et al., 2003).  
The zebrafish genome contains a high number of duplicated genes that derive from 
teleost-specific genome duplication. In the case of these three transcription factors, it was 
found that duplicated paralogous genes have not maintained a redundant role in thyroid 
development. For hhex, only this single gene can be found in the zebrafish genome 
(Elsalini et al., 2003). The Nkx2.1 gene is duplicated in zebrafish, but only nk2.1a is 
expressed in thyroid (Rohr and Concha, 2000). In the case of pax2.1/pax8, it was shown 
that both are expressed in zebrafish thyroid with pax8 acting downstream of pax2.1, and 
that pax2.2 is not expressed in thyroid (Wendl et al., 2002). Concerning Foxe1, only one 
ortholog, foxe1, was found in the zebrafish genome, which is expressed in thyroid 
primordium. However, this gene is not functionally involved in thyroid development, in 
contrast to its role in mouse and human. However, it cannot be excluded the possibility that 
an unknown foxe1 paralog and/or other foxe gene(s) may compensate for the loss of foxe1 
activity in zebrafish thyroid (Nakada et al., 2009). 
 
 
 Figure 13 (A) Thyroid expression profile of zebrafish embryos at 
30 hpf. All the transcription factors reported are expressed in 
thyroid primordium (arrow). (B) Nk2.1a is required in the late 
stage of thyroid development: in wild-type (WT) embryos the 
thyroid primordium (arrow) is visible at 30 hpf and at 60 hpf 
stained with hhex probe; in the embryos injected with a 
morpholino against nk2.1a mRNA (nk2.1a MO) the thyroid 
primordium is present at 30 hpf but disappears at later stage. 
Lateral view are reported, anterior to the left. Stages are 
indicated bottom right, genotype top right and staining/marker 
top left. 
 
 
Thanks to the zebrafish studies, new knowledge about the induction of thyroid fate 
was obtained. In particular, the first direct evidence for a role of FGF in the induction of 
thyroid fate comes from studies in zebrafish (Wendl et al., 2007). Exposure of early 
embryos to an inhibitor of FGF at a stage prior to specification leads to lack of thyroid 
primordium without global defects in endoderm patterning. A similar phenotype is found 
in embryos mutant for the transcription factor hand2 that has been suggested to be 
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upstream of FGF (Abe et al., 2002). This effect is most likely due to hand2 activity in the 
cardiac lateral plate mesoderm, where this gene is expressed, juxtaposed to the thyroid 
anlage. It is conceivable that hand2 is necessary for the development of certain tissues 
(most probably lateral plate mesoderm or heart) in the vicinity of the endoderm. Thyroid 
development, in turn, depends on the proper development of these surrounding structures 
because if the development of adjacent tissue is impaired also local sources of signaling 
molecules, such as FGFs, could be deficient. Hence, these findings elucidate also how the 
interaction between mesoderm and endoderm is fundamental for proper thyroid 
specification and development in zebrafish. As reported above, recent work in mouse 
models has confirmed and further elaborated these findings (Kameda et al., 2009; Lania et 
al., 2009). 
In addition to the surrounding  mesoderm, much attention has been paid to the possible 
involvement of embryonic vessels and endothelial cells as a source of inductive signals for 
endoderm derived organs. Like in mammals, the zebrafish thyroid primordium starts to 
develop near the outflow tract of the heart; from about 40 hpf, the globular primordium 
expands along the A-P axis into a strand of follicular tissue, thereby always remaining 
restricted to the midline. During the expansion phase, the thyroid tissue is in close contact 
with the growing ventral aorta that connects the heart to the branchial arteries. Considering 
that this aspect, is conserved in mammals and zebrafish, it was raised the question whether 
factors generated by the vessel wall or provided by the local circulation may influence 
early thyroid development. Works in zebrafish have clearly demonstrated that thyroid 
specification does not require a vascular signal. Specifically, in zebrafish lacking Scl, vegf 
or Kdr functions, in which the vascular patterning of the thyroid specification zone of the 
endoderm is severely disturbed, thyroid progenitors are readily specified (Alt et al., 2006a). 
Likewise, in cloche mutants lacking all vascular progenitors of the anterior trunk, the 
thyroid primordium is present (Alt et al., 2006a). Even if normally differentiated, the 
thyroid follicles in these mutants were mislocalized and irregularly distributed around the 
cardiac outflow tract, indicating that vascular cells influence thyroid morphology rather 
than thyroid induction (Alt et al., 2006a).   
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2. Aim of the present project 
As described in the introduction section, there is a series of aspects concerning the 
thyroid development that remain unknown. The necessity to elucidate this missing 
information is by no means solely academic, since identification of the molecular 
mechanisms involved in any steps of thyroid development will likely provide clues to 
novel pathogenetic mechanisms of thyroid dysgenesis. To date, only in 5% of the patients 
with TD examined it was found a mutation in the known thyroid genes. This number could 
be an underestimate because the mutation analysis was limited to the coding regions of the 
genes examined, excluding potential disease-causing mutations in non-coding regions of 
the same genes. Still, the low frequency of mutation in the genes studied thus far suggests 
that other genes and/or mechanisms could be involved in the pathogenesis of TD. 
Many efforts are being devoted to understand the mechanisms by which thyroid 
precursors cell specification, thyroid primordium migration and final organ shaping occur. 
In particular, the genes involved in the transcriptional regulation of the thyroid 
transcription factors Nkx2.1, Hhex, Pax8, Foxe1, as well as their downstream genes that 
ultimately actuate the specific thyroid developmental program are still unknown. Different 
experimental strategies are currently used from different research groups to investigate 
these aspects.  
In the case of my PhD project, it was decided to use a comparative approach to 
contribute to the elucidation of the genetic mechanisms underlying the early steps of 
thyroid development. In particular, my objective was to use the zebrafish as a model for 
validating genetic information preliminarily gained in the mouse model system, taking in 
mind that comparison between related species may be a successful approach to uncover 
conserved and divergent principles of development. 
Embryonic thyroid-enriched gene lists obtained combining Laser Capture 
Microdissection (LCM) and microarray technology in mouse model were the starting point 
of my PhD project. Three mouse transcriptomes, from thyroid bud, lung bud and whole 
embryo, have been compared and two different gene lists, thyroid enriched and enriched in 
both thyroid and lung were generated (Figure 14 A). Significantly enriched GO categories in 
which these thyroid enriched genes are classified are reported in Figure 14 B.         
The main aim of the present work was to identify new genes involved in thyroid 
development, by functional analysis in the zebrafish system of the mouse thyroid enriched 
genes.  
It was decided to conduct this work proceeding through three steps/objectives that 
have been approached in a chronological order. The first point was the identification of the 
zebrafish orthologs of the murine thyroid enriched genes by searching in publicly available 
genomic databases; the orthologs identified were either cloned from zebrafish embryo 
cDNA or purchased from a distributor of clones generated by the I.M.A.G.E. Consortium. 
The second point was the expression profile analysis of the zebrafish orthologs in order to 
verify their transcription in the developing thyroid; this step was performed with the 
application of whole-mount in situ hybridization (WMISH) technique. The last point was 
the functional analysis of the genes whose expression was found to be conserved in 
zebrafish thyroid, with the aim to characterize the thyroid phenotype.  
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Figure 14 (A) Scheme describing mouse thyroid enriched genes lists generation: thyroid bud transcriptome and lung 
bud transcriptome were compared to whole embryo transcriptome to highlight thyroid bud enriched and lung bud 
enriched genes lists; comparing the thyroid enriched genes with the lung enriched genes, the genes enriched only in 
thyroid bud and the genes enriched in both tissues were selected. (B) Significantly enriched Gene Ontology 
categories in which the thyroid enriched genes are classified.  
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3. Material and methods 
 Zebrafish care and preparation of specimens 
The work on zebrafish Danio rerio, was carried out essentially according to standard 
procedures (Westerfield, 2000) and staging refers to the development at 28.5-29°C. The 
noi
tu29
 mutant fish lines was used (Lun and Brand, 1998). 
To perform WMISH and whole mount immunohistochemistry (WMIHC) experiments, 
embryos were dechorionated manually and anaesthetized in tricaine before fixed over night 
using 4% Paraformaldehyde (PFA) in PBS. Then they were washed in PBS containing 
0.1% Tween 20 (PBT) and stored in methanol at -20°C. 
 Embryonic manipulation 
Morpholinos were acquired from Gene Tools (Corvallis, OR) and dissolved as 
recommended by the provider. Morpholino sequences are: hhex: 5’-
gcgtgcgggtgctggaattgcatga-3’; nk2.1a: 5’-gctcaaggacatggttcagcccgc-3’; bcl2l: 5'-
aggttgttgctcgttctccgatgtc-3'; pax8-1: 5’-gttcacaaacatgcctcctagttga-3’; pax8-2: 5’-
gacctcgcccagtgctgttggacat-3’; control: 5’-cctcttacctcagttacaatttata-3’. The bcl2l full-length 
mRNA was synthesized by in vitro transcription reaction from the pCS2+ bcl2l construct 
(see below for the construction of the plasmid) using the SP6 polymerase (Ambion kit). 
Microinjection setup and embryos were prepared and injected according to Rembold et al., 
2006. Morpholinos and mRNA were always injected into one-cell-stage embryos. 
 Probes preparation and Whole Mount In Situ Hybridization (WMISH) 
The template to synthesize the probe was prepared by either linearizing a plasmid or 
by PCR on plasmid. The plasmid, containing the template to be transcribed, has been 
digested with the appropriate restriction endonucleases, following the manufacturer’s 
instructions, and purified with a classical phenol:chloroform:isoamylic alcohol extraction. 
1 μg of purified, linearized DNA has been used as template for ribonucleic probe synthesis 
labeled with digoxigenin (DIG) or fluorescein (Fluo). When the plasmid containing the 
template to be transcribed was not provided of RNA polymerase binding site, the template 
was amplified by PCR using a reverse primer that introduce at 3’ end of the fragment the 
T3 binding site. The amplified product was then purified by agarose gel extraction. The in 
vitro transcription reactions were performed using the appropriate RNA polymerase, Sp6, 
T7 or T3 (Roche) following the manufacturer’s instructions. The synthesized ribonucleic 
probes have been purified with the mini Quick Spin RNA Columns G-50 Sephadex 
(Roche), following manufacturer instructions and their quality has been checked by gel 
electrophoresis. The recovered samples have been immediately stored at -80°C till the use. 
Embryos stored in 100% methanol at -20°C were washed twice with PBT, digested 
with 10 mg/ml proteinase-K in PBT for several minutes depending on the stage, washed 
further and fixed again in 4% PFA for 20 min. After additional washes, the embryos were 
prehybridized in hybridization mix (HM) (50% formamide, 1.33X SSC, 0.2% Tween20, 
100 μg/ml Heparin, 50 μg/ml yeast or torula RNA, 5 mM EDTA ph8, 0,5% chaps) for 2-4 
h at 63°C and then DIG-labelled RNA probe or Fluo-labelled RNA probe was added (1μl 
for 300μl of hybridization mix). The embryos were then submitted to several washing 
treatments at 63°C: 5 min in HM/2XSSC (75:25); 5 min in HM/2XSSC (50:50), 5 min in 
HM2XSSC (25:75), 10 min in 2XSSC, 30 min in 0,2XSSC. Then they were rinsed once 
with warm 0.2SSC and let them cold to RT. Once reached room temperature (RT), 
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embryos were washed with MBT for 5 minutes and then incubated in 2% blocking reagent 
(Roche) for at least 2 hrs at RT. The antibody incubation step is usually performed ON at 
4°C, diluting the appropriate antibody in 2% blocking reagent with the following 
proportions: 1:5000 for Fab-AP α-DIG and 1:2000 for Fab-AP α-Fluo (Roche). The 
following day, the antibody was removed and embryos washed four times in MBT for 15 
min each and with MAB with 0,1% Tween 20 for 30 min. Then, for staining reactions with 
BMpurple (Roche) that gives the blue precipitate, it was performed an incubation in a 
solution containing Tris-HCl 0.1M pH 9.5 and 0.1% Tween 20 for 30 min followed by a 
wash in NTMT (0.1 M Tris pH 9.5, 0.05 M MgCl2, 0.1 M NaCl, 1% Tween 20) for 30 
min, before the staining reaction. For staining reactions with Fast Red tablets reagent 
(Roche) that gives the red precipitate, samples were incubated in a solution containing 
Tris-HCl 0.1 M pH 8.2 and 0.1% Tween 20 for 30 min, followed by the staining reaction 
with Fast Red (1 tablet/ml in Tris-HCl 0.1 M pH 8.2). The staining reaction was stopped 
by the addition Stop solution (1X PBT, 1mM EDTA pH 8.0), followed by the fixation in 
4% PFA. The stained embryos were then washed in PBT, gradually transferred to 90% 
glycerol and studied for detailed analysis.  
In double in situ experiments, embryos were hybridized with two different probes: the 
strongest one labeled with Fluo and the weaker with DIG. The first detection was usually 
performed for the DIG-labeled probe with BMpurple and the second for the Fluo-labeled 
probe with Fast Red. After the first detection, embryos were washed with Stop Solution 
and the Fab-AP α-DIG was inactivated with a 10’ wash in 0.1 M Glycine pH 2.2 with 
0.1% Tween 20. Then, embryos were rinsed in MABT for few minutes, incubated in Block 
and finally with the second antibody.  
 Double staining (WMISH + WMIHC) 
For tg immunodetection, the ISH was stopped with PBT and the in situ hybridized 
zebrafish embryos were washed further 5 times in PBT. Then, they were treated in dark 
with 10% H2O2 in PBS for 15 min to block endogenous peroxidases, rinsed twice with 
PBT, post-fixed in 4% PFA for 15 min and washed 5 times in PBT for 5 min each. They 
were then incubated with 3% normal goat serum (NGS) for 2 h, then with polyclonal anti-
human thyroglobulin antibody (Dako) (dilution 1:6000 in 3% NGS) for 2 h and washed 
several times in PBT for 3 h or ON. They were then incubated with anti-rabbit biotinylated 
secondary antibody (Vectastain) (dilution 1:200 in 3% NGS) for 2 h, washed several times 
in PBT for 3 h or ON and further incubated with the ABC reagent (Vectastain) for 2 h (1 
ml PBT + 20 l A + 20 l B). After several washes in PBT for 3 h, the embryos were 
stained with DAB (1: 5) in PBS with 0.3% H2O2 for 30 min and observed while staining. 
All the incubations with 10% H2O2 in PBS, 4%  PFA, NGS, primary antibody, secondary 
antibody and DAB were carried out at RT.  
For active-caspase-3 immunodetection, the ISH was stopped with PBT and the in situ 
hybridized zebrafish embryos were washed further 5 times in PBS+TritonX (0,1%). Then, 
they were treated with pre-cooled acetone for 20 min at -20°C, washed in PBS+TritonX 
(0.1%), treated in dark with 10% H2O2 in PBS+TritonX (0.1%) for 30 min to block 
endogenous peroxidases and washed again in PBS+TritonX (0.1%). They were incubated 
in blocking solution (5% NGS + 2mg/ml BSA) for 2 h at RT and then with the anti-human 
active-caspase-3 antibody (BD Biosciences) (dilution 1:500 in blocking solution) ON. 
They were then washed 3 times in PBS+TritonX (0.1%) for 20 min each and incubated for 
2h in anti-rabbit  biotinylated secondary antibody (Vectastain) (diluition 1:1000 in 
blocking solution). After 3 washes in PBS+TritonX (0.1%) for 20 min each, the embryos 
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were incubated with the ABC reagent (Vectastain) for 45 min (1 ml PBT + 5 l A + 5 l 
B). The staining was performed with DAB as reported above. 
 RNA extraction, cDNA synthesis and cloning procedures 
Total RNA was extracted from whole zebrafish embryos at 24, 48 and 72 hpf using 
TRIzol Reagent (Invitrogen), according to the manufacturer’s instructions. Residual DNA 
was digested with DNAse I using a DNA-free kit (Ambion, Austin, TX). The 
concentration of RNA was estimated using a NanoDrop ND-1000 spectrophotometer and 
its integrity by gel electrophoresis. 
4 gs of total RNA were used as template for the synthesis of the first cDNA strand 
starting reverse from oligo dT primers, using the Superscript II Reverse Transcriptase kit 
(Invitrogen) according to the manufacturer’s instructions. 
Gene fragments to use as templates for probe preparation and WMISH experiments 
have been amplified by PCR using gene-specific oligonucleotides (Table 1) and cloned by 
TOPO-TA cloning (Invitrogen), according to manufacturer instructions. 
Table 1 Oligonucleotide list  used for cloning 
Zebrafish gene symbol Primer forward sequence Primer reverse sequence 
irgf3 - LOC797731 AACTCAGAATGACTTGGAGG CTAGACTTCAGTCTCCAGTG 
LOC565002 CCAAACGTTCAAACATAATGTC AGGTTATCTTCTTTGTGAGGG 
LOC100007513 CTGATGGTGTTATAAACATGAACTG TGAAAGCCTCGCCAGTGATCC 
Prlra TGCAGATTTAATATCGCAAGCAGC GGAAGAAGCCCAGCTTGTTT 
Prlrb GTCATTCTCCACCAGGGAGG TGATGGTCCGTGCTCTGGGATA 
si:dkey-5n4.1 GGAATGGTCATTCTTACCCTGTGC GACTCATAGTCTGACAGGCCTTTG 
NP_001038642.1 GATCATCCCATATGACTTCAACAG CATATATCCATCTATGTGTGAGAGC 
LOC567443 GATCATCCCATATGACTTCAACAG GACGCGGTCCAGCGGAGCATTG 
lypd6b GTGTCACTAACAGCGTCTCAAAC GTGGCATGAGTCCAGACAGAGCGG 
A2CE94_DANRE ACCCTCAGCATTTGTCGCAAAG GGCGATGGGGATCTAAATGATGGC 
LOC100000503 GAGCAGGGAGGGCAAGATTCCG AATGGAGGTGAGGTGTACTGCTGT 
LOC794722 CCCGACTCACAGCGACACTCTGC CAGTGATGGGCGCTGTTATATGGC 
clstn2 GCATGAAGATGCGCGCGATAAC TGCCGTCCAATTGGTGGATGTGCT 
LOC569664  GGTTTCCACGTGCAGGGCCTCAG GAGAGTCACCGTCCAGTTACATAC 
CHDH CAGCAGGCTGGATACCCCTACAC TAATGGCGTCCGCCGCTTTCTCTG 
LOC562973 CAAAATATGTGTCTTCTGCT TGCTCCCACTCTTCTGAATC 
ENSDARG00000073889 CGTTCCTCCATCGGAAACCA GCAATGTACTCTTCCTCATCCC 
LOC562570 ACTGCTGGCTCATAGAAGGT GCCACACAGTAGGTGTAATC 
sich211-210c8.8 GGTTGTCGATCCCAGGGCAA CGTGGAGAGATGCTGAAGAG 
socs2 ATGACCTGTCACTCATCCGA TATAAGTGTAGTCTGTCAGGTA 
SORL1 CAATGAGAGCAGCTCAGTTTAACA CCATTAAAGCAGGTGGCGTGAGGA 
zgc:101788 CTGCTAGCAAACAGAGGGAC TAACTGGCACAACGCTGTTT 
B8A438_DANRE TCAAGACACTGCAAGAAGGAGAGA AGCATATATGCCATTGTCGGAAAC 
Q32PL4_DANRE ATCCGGTCTTCAATAATGGC CAGTGTAAATCACAGGTGTC 
cdh1 ATGGCTTGTGTAACAACTGTGGG TCTGGATCAATGGCTGTAAAAGGG 
si:ch211-81i17.1 GAGGAGTTTCAGTTCCTTCAGGC CAGGAAGTGAGGAGGACAGCC 
cadherin 16 GAGTATAGTCTTGAGGGAGAGTT GCTGTGGATGCAGGTCCGTAT 
bmf1 ACGAGGATGATGTGTTCAGGA ACCTGCGGTTCTCTCTGGC 
 
To produce the pCS2+ bcl2l construct, the bcl2l cDNA was amplified from the clone 
IRBOp991H0214D from the IMAGE Consortium using the following primers: forward 
primer 5’- ATCCGGAATTCAATTATGTCTTACTATAACCGA-3’ containing a EcoRI 
restriction site in 5’ tail; reverse primer 5’- 
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TTGCTCTCGAGTTATCCTCATCTTCACAG-3’ containing a XhoI restriction site in 5’ 
tail. Then, the amplified bcl2l cDNA was digested with EcoRI and XhoI and cloned in 
EcoRI and XhoI sites in pCS2+. 
All the standard molecular biology techniques were carried out according to Sambrook 
et al., 2001; plasmids were transformed into the E. Coli k12 strain and cultured in 5 ml LB 
medium containing appropriate antibiotics; the DNA was then purified using Qiagen Mini 
prep kits (Qiagen). 
 Identification of zebrafish orthologs in Ensembl and NCBI databases 
   Zebrafish orthologs have been identified by means of successive steps: first of all 
Ensembl databases were checked looking for the zebrafish genes already annotated as 
orthologs of the mouse thyroid enriched genes; the orthologs identification was then 
confirmed and completed by browsing Ensembl (http://www.ensembl.org/index.html) and 
NCBI (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) peptide databases, using mouse 
protein sequence as query and BLATP as search tool. The criteria adopted for a likely 
ortholog was > 40% amino acid identity over the entire length of the protein. When more 
than two sequences showed a good identity percentage to the query, they were align with 
the mouse protein sequence using an online available multialignment tool 
(http://multalin.toulouse.inra.fr/multalin/multalin.html). Analyzing the multialignment the 
proteins, that showed the higher identity to the mouse protein in the domains relevant for 
the protein function, were selected as zebrafish ortholog proteins.  
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4. Results and discussion 
 Zebrafish analysis of mouse thyroid enriched genes 
Identification of the zebrafish orthologs of the murine thyroid 
enriched genes 
We decided to focus our study on the genes enriched in mouse thyroid bud and on that 
enriched in both mouse thyroid bud and lung bud, overcoming a fold change 10.  
These two gene lists consist of a total of 92 genes (excluding the already known 
thyroid genes). Furthermore, other 11 thyroid-enriched mouse genes with a fold change 
lower than 10 were selected, for the study, because of their implication in molecular 
processes candidate to be relevant for thyroid development. 
To find the putative zebrafish orthologs of the mouse thyroid-enriched genes, the last 
version of the ongoing zebrafish genome sequencing project (Zv8, June 2008) was 
analyzed by performing BLAST alignments against the zebrafish Ensembl databases. The 
obtained results were confirmed and sometimes completed performing the BLAST search 
in the zebrafish NCBI databases. For 90 mouse genes (88% of investigated genes) a total 
of 167 putative zebrafish orthologs were identified; in particular, for each of 40 mouse 
genes two zebrafish orthologs were found, in line with the whole genome duplication event 
occurred during the early evolution of teleost fishes (e.g., prlra and prlrb are the two 
zebrafish orthologs of the mouse Prlr); for each of 37 mouse genes only one zebrafish 
ortholog was found, in line with the gene loss events occurred after the zebrafish whole 
genome duplication (e.g., zgc:158317 is the only zebrafish ortholog of the mouse Zbtb20); 
for each of 13 genes more than two zebrafish orthologs were found (e.g., tcfcp2l1,  
si:ch211-207c15.3 and sich211-210c8.8 are the three putative zebrafish orthologs of the 
mouse Tcfcp2l). This latter aspect could be due to single gene duplication events occurred 
in addition to the whole genome duplication or could be a consequence of large gene 
family in which it is difficult to identify the “true” orthologous genes (e.g., 10 putative 
zebrafish orthologs were found for the mouse gene Iigp). Finally, zebrafish orthologous 
matches were not found for 13 mouse genes probably because the zebrafish genome is not 
fully completed or because of genes loss during the genome evolution (e.g.,  
4930426D05Rik, Cd44). 
The gene lists, with the zebrafish orthologs identified are reported in Appendix (Table 
5, Table 6 and Table 7). 
Expression patterns analysis of the putative zebrafish orthologs 
After the identification of the zebrafish orthologs of the mouse thyroid-enriched genes, 
their expression profile was investigated, during zebrafish embryonic development, to 
evaluate the conserved expression in thyroid primordium. The spatiotemporal expression 
pattern of these orthologs was analyzed by means of WMISH. With this purpose, gene 
fragments to use as templates for the synthesis of digoxigenin-conjugated riboprobes have 
been gained following two main approaches: EST databases have been screened for clones 
of genes of interest, which have been commercially acquired from the I.M.A.G.E. 
Consortium; otherwise, gene-specific PCR primers have been used for amplification from 
total cDNA. Through these two approaches, acquisition and cloning, 104 clones resulted 
available for the expression profiles analysis (~62% of the orthologs). The expression 
pattern was studied at different developmental stages starting from the first appearance of 
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thyroid primordium in zebrafish embryo (24 hpf) until the distribution of the functional 
thyroid follicle in their final position along the ventral aorta (96 hpf). The embryonic 
territories in which these genes were found expressed are reported in Appendix (Table 5, 
Table 6 and Table 7).      
On the basis of the expression profiles observed, it is possible to cluster the genes 
analyzed in three groups: a) the genes that are expressed neither in thyroid region nor in 
surrounding tissues; b) the genes expressed in surrounding tissues but not in thyroid 
region; c) the genes expressed in thyroid region. The majority of the genes studied are 
included in the first group: despite their unquestionable expression in other embryonic 
tissues, they resulted clearly not expressed in zebrafish thyroid in any embryonic stages 
analyzed. The second group includes 37 zebrafish orthologs, corresponding to 32 mouse 
genes, expressed in the tissue surrounding the area of thyroid primordium development, 
such as the pharyngeal endoderm, pharyngeal arches, heart field, but clearly not expressed 
in thyroid. In Figure 15 there are reported the nk2.1a expression profile as an example of 
thyroid staining (Figure 15 A-B-C) and some examples of genes expressed in adjacent tissues 
(Figure 15 D;O).  
 
Figure 15 Example of WMISH of genes expressed in tissues nearby the thyroid primordium. Stages are indicated 
bottom left, staining/marker top left. Lateral (A-B-D-F-H-J-L-M-N-O) and ventral (C-E-G-I-K) views are shown with 
anterior to the left. (A-B-C) nk2.1a expression profile showing the thyroid primordium position at 24, 48 and 72 hpf. t, 
thyroid; tf, thyroid follicles; h, heart; p, pharynx; pe, pharyngeal endoderm. 
In zebrafish, lypd6b (Figure 15 D-E), the ortholog of the mouse gene identified as 
2310010M24Rik, and LOC569664 (Figure 15 F-G), the Clstn2 ortholog, are expressed in the 
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heart at 48 and 72 hpf. It is worth noting that the heart field and the thyroid primordium are 
in contact in zebrafish embryo especially from 24 to 48 hpf, making it difficult to discern a 
thyroid signal from a cardiac one. Cdh1, also known as E-cadherin, a well known thyroid 
epithelial marker (Fagman et al., 2003), is present in our lists; four putative orthologs were 
identified for this gene but only two, cdh1 (Figure 15 H-I) and LOC567602, could be ISH 
assayed, both showing a strong expression in the pharynx, according to mouse Cdh1 
expression in the foregut endoderm, but clearly not in thyroid primordium. According to 
the gene chip analysis, Stc2 was 30 times overexpressed in thyroid tissue; the mouse E10 
thyroid expression of this gene was also confirmed by in vivo experiments. Stc2 zebrafish 
ortholog, LOC558195, was expressed in cartilaginous segments of the pharyngeal region  
but not in thyroid primordium  (Figure 15 J-K). The Egfl6 ortholog, egfl6 (Figure 15 L-M) and 
the St14 ortholog, LOC557248 (Figure 15 N-O) were both expressed in pharyngeal tissues at 
24 and 48 hpf. 
From the current analysis, the only genes found to be expressed in thyroid primordium 
are: 1) htra1, ortholog of Htra1; 2) A2BFE2_DANRE, ortholog of Ltbp3; 3) 
Q06Z31_DANRE, ortholog of Zbtb4; 4) LOC100151488, ortholog of Dock9; 5) bmf1, 
ortholog of Bmf1; 6) chdh, ortholog of Chdh. 
The divergence observed in thyroid expression profile between zebrafish and mouse 
was not expected in consideration of the high conservation of the molecular mechanisms 
responsible for thyroid primordium differentiation, and of the homology in thyroid 
function.  
This divergence could be explain taking into account the different morphology of the 
differentiated gland. In zebrafish, as well as in the adult lamprey and the other bony fishes, 
the thyroid is not encapsulated and the follicles are widely scattered along the ventral aorta, 
either single or in small clusters. During this morphological transformation from lower to 
higher vertebrates, occurred after that the biochemical evolution of the gland had ceased, 
the thyroid of the higher vertebrate have acquired the function to group the follicles and to 
become encapsulated, probably through adaptive mutations in cis-regulatory regions, 
bringing new functions under the control of a thyroid expressed transcription factor. So the 
high number of genes enriched in mouse thyroid and not expressed in zebrafish thyroid 
could be explain considering this aspect. 
In the current analysis, a good percentage of mouse thyroid enriched gene orthologs 
was found to be expressed in tissues near the zebrafish thyroid instead of the thyroid itself. 
It has been hypothesised a mechanism of homeogenetic transfer during thyroid evolution 
(Yu et al., 2002): FoxE4, the ancestral precursor of the vertebrate thyroid-specific Foxe1, 
was likely recruited in the endostyle, the invertebrate chordate thyroid homolog, from an 
adjacent region of the pharynx. A similar mechanism could have occurred during the 
evolution of one or more of the zebrafish genes expressed in surrounding tissues. 
In addition, it cannot be excluded the possibility that unidentified or unchecked 
zebrafish orthologs/paralogs still retain the thyroid function.         
Expression analysis of the zebrafish putative thyroid genes  
Htra1 is a serine protease belonging to the high-temperature requirement factor A 
protein family with the ability to regulate TGF-β (transforming growth factor-β)/BMP 
(bone morphogenetic protein) signaling (Canfield et al., 2007). Two Htra1 orthologs were 
found in zebrafish genome: htra1 and zgc:172061. Htra1 was found to be specifically 
expressed in the heart field, probably the bulbus arteriosus, and in the thyroid region, 
starting from 48 hpf (Figure 16). Actually, htra1 expression domain appears much more 
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extended than the typical thyroid signal; the double staining for htra1 mRNA and tg 
protein shows that the thyroid follicles are surrounded by the htra1-positive cells (Figure 
16D). 
 
 
Figure 16 Expression profile of htra1, zebrafish ortholog of murine Htra1, by in situ hybridization assay. Stages 
are indicated bottom left, staining/marker top left (when it is different from htra1). Lateral view (A) and ventral view 
(B-C-D) with anterior to the left are shown. At 48 and 72 hpf htra1 is expressed in thyroid region (arrow) and in the 
bulbus arteriosus (arrowhead). In (C), a ventral view of 72 hpf embryo stained with the tg antibody, a marker of 
thyroid follicles. In (E) is reported the co-staining with htra1 probe (blue) and tg antibody (brown). 
The latent transforming growth factor beta binding protein 3 (Ltbp3) is an extracellular 
matrix protein able to modulate the TGF β bioavailability (Chen et al., 2003). Starting from 
24 hpf, the zebrafish ortholog of Lbtb3, A2BFE2_DANRE,  is expressed in the heart field, 
probably in the bulbus arteriosus, and in the region where the thyroid primordium is 
located (Figure 17). Actually, A2BFE2_DANRE is expressed in a wider region that includes 
the thyroid primordium; in particular, the double staining for A2BFE2_DANRE mRNA 
and tg protein at 72 hpf shows that the thyroid follicles are located in the 
A2BFE2_DANRE positive region (Figure 17D).  
 
 
Figure 17 Expression profile of A2BFE2_DANRE, zebrafish ortholog of murine Ltbp3, by in situ hybridization 
assay. Stages are indicated bottom left, staining/marker top left (when it is different from A2BFE2_DANRE). Lateral 
view (A-B) and ventral view (C-D) with anterior to the left are shown. Starting from 24 hpf A2BFE2_DANRE is 
expressed in thyroid (arrow) and heart region (arrowhead). In (D) is reported the co-staining with the A2BFE2_DANRE 
probe (blue) and the tg antibody (brown). 
Zbtb4 is a transcriptional repressor able to recognize methylated DNA through a 
Kaiso-like zinc finger domain (Filion et al., 2006). It is involved in the cell cycle regulation 
by transcriptional repressing P21CIP1, an inhibitor of the Cdk2 kinase (Weber et al., 
2008). The zebrafish genome contains Q06Z31_DANRE, the only Zbtb4 ortholog, whose 
expression profile was analyzed (Figure 18). This gene seems to be expressed in thyroid 
primordium starting from 30 hpf. A double staining for zbtb4 mRNA and tg protein shows 
a colocalization of the two signals (Figure 18 E).  
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Dock9, dedicator of cytokinesis 9, is a guanine nucleotide exchange factor able to 
activate the small G-protein Cdc42. The only known physiological function of this protein 
is the involvement in the dendrite growth in hippocampal neurons (Kuramoto et al., 2009). 
Two orthologs for Dock9 were found in the zebrafish genome, dock9 and LOC100151488, 
both expressed in pharyngeal region. Starting from 35 hpf, LOC100151488 shows a typical 
thyroid expression profile (Figure 19). Double in situ hybridization shows that this gene is 
expressed in a territory that partially overlaps with tg-positive cells (Figure 19 E). 
       
Bcl2-modifying factor (Bmf) is a member of the BH3-only group of proapoptotic 
proteins that is implicated in cell death caused by anoikis, histone deacetylase inhibitors, 
transforming growth factor β, and tumor necrosis factor α (Hubner et al.). Of the two 
zebrafish orthologs, bmf1 and bmf2, bmf1 expression profile was analyzed, finding that, at 
48 hpf, the gene is expressed in thyroid region (Figure 20). Double in situ hybridization 
shows that the bmf1 signal is partially overlapping with tg signal (Figure 20 B) and it is 
localized in the posterior part of thyroid primordium. 
 
 
Figure 19 Expression profile of LOC100151488, 
zebrafish ortholog of murine Dock9, by in situ 
hybridization assay. Stages are indicated bottom 
left, staining/marker top left (when different 
from LOC100151488). Lateral with anterior to 
the left (A-D-E) and dorsal with anterior to the 
top (B-C) views are shown. At 35 and 48 hpf, 
LOC100151488 is expressed in a region 
corresponding to the thyroid primordium 
position (arrow) (A-B-D).  In (C) is reported 
ventral view of hhex-stained embryo to show 
the thyroid primordium in a ventral view. (E) 
shows a double in situ hybridization for 
LOC100151488  (blue) and tg (red). 
Figure 20 Expression profile of bmf1, zebrafish ortholog of murine 
Bmf, by in situ hybridization assay. Stage is indicated bottom left, 
staining/marker top left (when it is different from bmf1). Lateral 
view with anterior to the left are shown. At 48 hpf bmf1 is 
expressed in thyroid region (arrow). In (B) is reported a double in 
situ hybridization for bmf1 (blue) and tg (red). 
Figure 18 Expression profile of 
Q06Z31_DANRE, zebrafish ortholog of murine 
Zbtb4, by in situ hybridization assay. Stages 
are indicated bottom left, staining/marker top 
left (when it is different from 
Q06Z31_DANRE). Lateral view with anterior to 
the left are shown. Starting from 35 hpf, 
Q06Z31_DANRE is likely expressed in thyroid 
(arrow). In (D) is reported a 72 hpf pax8-
stained embryo to show the thyroid 
primordium in a lateral view at this stage. In 
(E) is reported the co-staining with 
Q06Z31_DANRE probe (blue) and tg antibody 
(brown). 
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Choline dehydrogenase (Chdh) encodes an enzyme involved in choline metabolism. It 
has been demonstrated that high level of choline in mother diet has a protective role 
against nonsyndromic cleft lip with or without cleft palate at birth (Shaw et al., 2006), and 
that specific polymorphisms in genes involved in choline metabolisms can influence the 
risk of this malformation (Mostowska et al.). The zebrafish genome contains one ortholog 
of Chdh, chdh. This gene was found to be expressed in thyroid region at 48 hpf (Figure 21). 
Double in situ hybridization shows a colocalization between chdh positive cells and tg 
positive cells (Figure 21B).  
 
Analysis of zebrafish bcl2 and bcl2l expression patterns during 
morphogenesis 
Experimental data, in both mouse and zebrafish, have demonstrated that in absence of 
the thyroid transcription factors, Nkx2-1/nk2.1a, Hhex/hhex or Pax8/pax2a, the thyroid 
primordium is specified but then disappears (Elsalini et al., 2003; Parlato et al., 2004). To 
date, no evidence is available about the fate of the thyroid cells deficient of their 
transcription factors; one possibility is that they undergo a degenerative process through an 
apoptotic program. 
In support of this hypothesis, the antiapoptotic factor Bcl2 was found 82 times 
overexpressed in thyroid tissue in the differential microarray analysis; the mouse E10 
thyroid expression of this gene was also confirmed by in vivo experiments (unpublished 
data). Analyzing the zebrafish genome, only one ortholog of this gene was found, bcl2, 
whose expression pattern was investigated during zebrafish development. WMISH clearly 
shows that bcl2 is expressed in otic vesicles, pectoral fin buds and pronephric ducts 
starting from 24 hpf but not in thyroid primordium in all the developmental stage studied. 
This expression pattern is maintained during later developmental stages (Figure 22).  
Considering the relevance that the presence of a 
survival mechanism could have in thyroid 
development, the expression pattern of bcl2l, 
another antiapoptotic factor of Bcl2 family, paralog 
of zebrafish bcl2 and ortholog of mouse Bcl-XL, was 
investigated in zebrafish embryos. This gene is 
expressed in thyroid primordium starting from 30 
hpf (Figure 23 A) throughout embryonic development 
(Figure 23D-E). The expression in the developing 
thyroid was confirmed by a double WMISH 
showing colocalization of bcl2l positive cells with tg 
positive cells (Figure 23H). Besides thyroid 
expression, bcl2l is transcribed also in some areas of 
the central nervous system (hindbrain, telencephalon 
Figure 21 Expression profile of chdh, zebrafish ortholog of 
murine Chdh, by in situ hybridization assay. Stage is indicated 
bottom left, staining/marker top left (when it is different from 
chdh). Lateral view with anterior to the left are shown. At 48 
hpf chdh is expressed in thyroid region (arrow). In (B) is 
reported a double in situ hybridization for chdh (blue) and tg 
(red). 
 
Figure 22  Bcl2 expression pattern in 
zebrafish embryo at 35 hpf, by in situ 
hybridization assay. Lateral views with 
anterior to the top are shown. In (A) arrow 
indicates otic vesicle, white asterisk pectoral 
fin bud, black asterisk lens. In (B) arrowheads 
indicates the pronephric ducts.  
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and diencephalon), in lens and in yolk extension. At 96 hpf, no bcl2l expression was 
detected in thyroid follicles suggesting that this gene is dispensable during late thyroid 
development.    
These data demonstrate the presence of an antiapoptotic function in thyroid that could 
be relevant for its development. This function is conserved during evolution: it is 
represented by Bcl2 in mouse thyroid (at date, there are no information about Bcl-XL 
expression in mouse thyroid) and by bcl2l in zebrafish. Furthermore, the presence of an 
antiapoptotic function in developing thyroid primordium suggests the idea that its role 
consists into suppress an hypothetical proapoptotic factor able to induce cell death against 
developmental defects. This idea is supported by the finding, exposed in the previous 
section, that the proapoptotic factor bmf1 is transiently expressed in a region overlapping 
with thyroid primordium (Figure 20). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 The role of bcl2l on zebrafish thyroid development 
Thyroid-specific transcription factors role on bcl2l expression  
Bcl2l starts to be expressed in zebrafish thyroid primordium few hours after the 
transcriptional activation of thyroid transcription factors expression. The role of these 
proteins on bcl2l thyroid regulation was investigated by means of mutant or morphants 
embryos (embryos in which the level of a specific protein is knocked-down using a gene-
specific morpholino). 
Figure 23 Bcl2l expression pattern in zebrafish embryo, by in situ hybridization assay. Lateral views with anterior to 
the left (A-C-D-E-F) and dorsal view with anterior to the top (B) are shown. Stages are indicated bottom left. (A-B-D-E) 
Bcl2l is expressed in thyroid (arrow), hindbrain, telencephalon, diencephalon and lens. (C) Expression in yolk 
extension. (F) Double in situ hybridization for bcl2l (blue) and tg (red). d, diencephalon; hb, hindbrain; t, 
telencephalon. 
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To study the role of pax2a on bcl2l thyroid 
expression, zebrafish embryos lacking pax2a 
activity, the noi
t29 
mutants (Lun and Brand, 
1998), were analysed (Figure 24). Homozygous 
mutant embryos have been identified according 
to characteristic morphological defects, in 
particular the hindbrain-mindbrain boundary 
absence (asterisk in Figure 24). It was found that 
bcl2l is not expressed in thyroid primordium in 
absence of pax2a (Figure 24 B), when the thyroid 
primordium is known to be still present, as it is 
confirmed by means of nk2.1a expression 
(Figure 24 D). Bcl2l expression in other tissue is 
not impaired in the mutant embryos.  
   The function of pax8 on bcl2l thyroid 
expression was investigated injecting the 
embryos with a combination of two already 
published morpholinos, able to target all pax8 
splicing isoforms (Mackereth et al., 2005). 2,5 
ng of each morpholinos were injected in one-
cell stage embryos. The efficacy of morpholino 
injection was evaluated according to the 
morphological alteration induced and already 
described (Mackereth et al., 2005). In pax8 
morphant embryos, bcl2l thyroid expression at 
48 hpf is comparable to the wild type, indicating 
that this factor is not involved in bcl2l thyroid 
regulation ( Figure 25 A-B). To date no published 
information on pax8 thyroid function in 
zebrafish are available; the thyroid phenotype 
was examined in these embryos checking the 
expression of thyroid transcription factors, but 
no anomalies were found (in Figure 25 C-D the 
result for hhex is shown as example), suggesting 
that pax8 is not involved in thyroid 
development in zebrafish. 
Some findings obtained in different model 
systems, have already demonstrated a transcriptional relationship between the Pax family 
transcription factors and the Bcl2 antiapoptotic proteins: a) in vitro experiments, with a 
mouse kidney cell line, demonstrated that Pax8 can transcriptionally regulate Bcl-2 (Hewitt 
et al., 1997); b) in vivo studies in C.elegans demonstrated that the two Pax2/5/8 genes act 
as transcriptional regulators of ced-9, the C. elegans bcl-2 gene (Park et al., 2006); c) in 
vitro studies on human rhabdomyosarcoma cell lines have demonstrated that BCL-XL is 
transcriptionally modulated by PAX3 (Margue et al., 2000). The results exposed here 
demonstrate that this relationship is conserved also in zebrafish thyroid; the transcriptional 
regulation of bcl2l in zebrafish thyroid primordium, in which two Pax genes are expressed, 
pax2a and pax8, is under the control of pax2a.     
Figure 24 Bcl2l expression in pax2a mutant 
embryos. Lateral views with anterior to the top are 
shown. Stage is indicated bottom left, genotype 
bottom right. (A-B) bcl2l expression in wild-type (A) 
and in noi
tu29
 embryo (B). (C-D) nk2.1a expression in 
wild-type (C) and noi
tu29
 embryo (D). Arrow 
indicates the thyroid primordium, asterisk the 
hindbrain-mindbrain boundary. 
Figure 25 Bcl2l expression in pax8 morphant 
embryos. Lateral views with anterior to the top are 
shown. Stage is indicated bottom left, genotype 
bottom right. (A-B) bcl2l expression in wild-type (A) 
and in pax8 morphant embryo (B). (C-D) hhex 
expression in wild-type (C) and pax8 morphant 
embryo (D). Arrow indicates the thyroid 
primordium.    
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The role of nk2.1a and hhex on bcl2l 
thyroid regulation was investigated by means of 
morpholino injection (Elsalini et al., 2003). 
Down-regulation of nk2.1a, obtained injecting 
2,5 ng per embryo of the specific morpholino, 
leads to the loss of bcl2l expression in thyroid 
primordium (Figure 26) when this is still present 
(30 hpf), as it is demonstrated by the 
persistence of pax2a staining (Figure 26 D). The 
expression of pax2a in the morphant thyroid 
primordium allows to exclude also that the 
effect observed on bcl2l transcription is 
secondary to an effect on pax2a transcription. 
As for pax2a and nk2.1a, when hhex is 
down-regulated, injecting 1,4 ng per embryo of 
the specific morpholino, the thyroid expression 
of bcl2l is lost (Figure 27); the staining for 
nk2.1a, at the same stage when bcl2l is no more 
expressed, demonstrates that the loss of bcl2l 
expression is not a consequence of the thyroid 
primordium disappearance (Figure 27 D).  
To recapitulate, bcl2l is not expressed in 
thyroid of both nkx2.1a and hhex morphant 
embryos as well as of noi
tu29
 mutants, at the 
stage when the thyroid primordium is known to 
be still present (Elsalini et al., 2003; Wendl et 
al., 2002). In these morphants/mutants, the 
thyroid primordium forms in its correct position 
but it subsequently degenerates and eventually 
disappears (Elsalini et al., 2003; Wendl et al., 
2002). So, the obtained results suggest that: a) 
bcl2l transcription is regulated by pax2a, hhex 
and nk2.1a; c) each of these factors is necessary 
but not sufficient to ensure bcl2l thyroid 
expression and that c) the loss of the anti-
apoptotic gene could have an important role in 
thyroid degeneration in the manipulated 
embryos. 
The regulation of bcl2l by pax2a, nk2.1a 
and hhex could be direct, if regulatory elements 
for these transcription factors are present in 
bcl2l promoter, or indirect, if one or more 
proteins, regulated by thyroid transcription 
factors, are able to bind and regulate bcl2l promoter. A preliminary analysis of bcl2l 
promoter region using TRANSFAC database indicate the presence of binding sites for 
Pax2 and Nkx2-1 transcription factors: this information should be confirmed by in vitro or 
in vivo experiments.   
Figure 26  Bcl2l expression in nk2.1a morphant 
embryos. Lateral views with anterior to the top are 
shown. Stage is indicated bottom left, genotype 
bottom right. (A-B) bcl2l expression in wild-type (A) 
and in nk2.1a morphant embryo (B). (C-D) pax2a 
expression in wild-type (C) and nk2.1a morphant 
embryo (D). Arrow indicates the thyroid primordium. 
The nk2.1a-MO was injected at a concentration of 
2,5 ng per embryo.   
 
Figure 27 Bcl2l expression in hhex morphant 
embryos. Lateral views with anterior to the top are 
shown. Stage is indicated bottom left, genotype 
bottom right. (A-B) bcl2l expression in wild-type (A) 
and in hhex morphant embryo (B). (C-D) nk2.1a 
expression in wild-type (C) and hhex morphant 
embryo (D). Arrow indicates the thyroid primordium. 
The hhex-MO was injected at a concentration of 1,4 
ng per embryo   
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Bcl2l functional analysis 
Engineering of zebrafish knockdown embryos for bcl2l 
In order to investigate the functional role of zebrafish bcl2l in thyroid development, a 
specific-bcl2l morpholino (Kratz et al., 2006), direct against the bcl2l ATG upstream 
sequence (Figure 28 A), was injected into one-cell stage embryos, to block mRNA 
translation, and the phenotype of these embryos was studied by analyzing the expression of 
thyroid-specific markers. 
Firstly, different concentrations of morpholino were 
injected into one-cell stage embryos with the aim to 
select a quantity capable of producing a specific 
phenotype. Injection of bcl2l-MO dramatically increases 
the mortality rate of zebrafish embryos compared to 
embryos injected with a control-MO (Table 2), as it is 
expected considering the anti-apoptotic function of bcl2l: 
1,5 ng of MO leads to 100% death rate at 48 hpf; 
reducing the amount of injected MO the death rate also 
decreases. The following functional experiments were 
done injecting 0,83 ng of MO into one-cell stage 
embryos; using a lower amount of MO no morphological anomalies are visible. The 
embryos injected with 0,83 ng of MO show alterations at the level of the expression 
domains of bcl2l: almost all the injected embryos show alteration in the head region with 
widespread apoptosis in 40% embryos and hypoplastic central nervous system in 43%; 
another feature of these embryos is the absence of yolk extension occurring in 31% 
examined embryos (Figure 28 B;E). Almost all embryos do not survive after 96-120 hpf; 
considering that the injection efficiency is not absolute, probably the embryos-living up to 
120 hpf are non injected ones.   
 
 
 
Figure 28 Effects of bcl2l-MO 
injection in zebrafish embryo. (A) 
bcl2l-MO binding site sequence is 
shown in red, the start codon in 
green. (B) 30 hpf control-MO 
injected embryo. (C-D-E) 30 hpf 
bcl2l-MO injected embryos 
showing widespread head 
apoptosis (arrow in C), hypoplastic 
central nervous system (arrow in D) 
and absence of yolk extension 
(arrow in E). Genotype is indicated 
bottom right, percentage bottom 
left. The injected MO amount was 
0,83 ng per embryo.  
To confirm that the effect of bcl2l-MO injection is specific, rescue experiments were 
performed through co-injection of MO and corresponding bcl2l full-length mRNA at 1-cell 
stage. mRNA used for rescue should not have a MO-complementary sequence; otherwise, 
it may rescue the phenotype simply by titrating out the MO. To this purpose bcl2l cDNA, 
without 5’UTR containing the MO-complementary sequence, was cloned in pCS2+ vector 
MO amount 
per embryo 
Death rate at 48 hpf 
bcl2l-MO 
control-
MO 
1,5 ng 100% 25% 
1 ng 90% 20% 
0,83 ng 50% 22% 
0,6 ng 30% 22% 
Table 2 Optimization  of injected 
amount of bcl2l MO. 
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and the corresponding mRNA was produced by in vitro transcription. The injection of 200 
pg per embryo of modified bcl2l mRNA was able to rescue the morphological features 
induced by bcl2l MO (Figure 29) and to revert embryo mortality rate to normal level almost 
completely. These data indicate that bcl2l mRNA can compensate for the function 
impaired by the MO injection and that, therefore, bcl2l-MO is able to induce specifically 
bcl2l down-regulation.  
 
Figure 29 Co-injection of bcl2l MO and bcl2l mRNA. The MO was injected at 0,83 ng per embryo and the mRNA 
at 200 pg per embryo. In (A) representative examples of bcl2l-MO injected embryos are shown: arrow indicates an 
embryos with widespread apoptosis in the head; arrowhead indicates a dead embryo. In (B) representative examples 
of bcl2l-MO and bcl2l mRNA co-injected embryos are shown: the widespread apoptosis is almost completely 
abrogated.  
 
Thyroid phenotype analysis of bcl2l knocked-down embryos   
Embryos injected with bcl2l-MO alone or in combination with bcl2l mRNA were 
fixed at around 48 hpf and thyroid phenotype was investigated checking for expression of 
thyroid transcription factors (Figure 30). Embryos injected with 0,83 ng of control-MO were 
used as control. Thyroid primordium disappears or it is smaller in a high rate of morphant 
embryos compared to control MO-injected embryos, as it is demonstrated by the absent or 
reducing staining for all the thyroid markers analyzed. Looking at pax2a staining, it is 
evident that in 29% of morphant embryos thyroid primordium appears smaller than normal 
(Figure 30 B) and it is completely absent in 28% of embryos (Figure 30 C), for a total of 57% 
of bcl2l morphant embryos showing thyroid alteration. Similar results are obtained 
analyzing the embryos for the other thyroid markers. 
The thyroid phenotype observed is specifically due to bcl2l down-regulation and this 
is demonstrated by the finding that it is almost completely rescued by bcl2l mRNA co-
injection: this means that the thyroid bcl2l function, lost by means of MO injection, is 
regained by mRNA injection. Indeed, the majority of rescued embryos shows normal size 
thyroid primordium (Figure 30): in the case of pax2a the embryos percentage showing 
thyroid alteration is decreased to 28%. Statistics of this experiment is shown in Table 3.  
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Figure 30 Thyroid phenotype of bcl2l morphant embryos. Lateral views with anterior to the top of 48 
hpf embryos are shown. Genotype is indicated bottom left, percentage (indicating the incidence of the 
described phenotype) bottom right and staining/marker top right. Arrows point to thyroid primordium. 
The MO was injected at 0,83 ng per embryo and the mRNA at 200 pg per embryo. (A;E) pax2a expression 
in control-MO (A), in bcl2l-MO (B-C) injected embryos and in bcl2l-MO and bcl2l-mRNA co-injected 
embryos (D-E); (F;J) pax8 expression in control-MO (F), in bcl2l-MO (G-H) injected embryos and in bcl2l-
MO and bcl2l-mRNA co-injected embryos (I-J); (K;O) nk2.1a expression in control-MO (K), in bcl2l-MO (L-
M) injected embryos and in bcl2l-MO and  bcl2l-mRNA co-injected embryos (N-O); (P;T) hhex expression 
in control-MO (P), in bcl2l-MO (Q-R) injected embryos and in bcl2l-MO and  bcl2l-mRNA co-injected 
embryos (S-T). 
Considering the morphological alteration induced by bcl2l-MO injection in the head 
region of zebrafish embryos, to verify whether the thyroid phenotype is consequence of a 
general reduction of foregut endoderm or is a 
more “specific” and restricted phenotype, the expression of foxa3, a ubiquitous marker of 
endoderm, was checked in bcl2l morphants (Figure 31). No significant alterations in foregut 
endoderm were observed in the manipulated embryos, demonstrating the specificity of the 
thyroid phenotype.    
These results indicate that bcl2l is indispensable for proper thyroid development and 
that its missing expression in the morphant embryos for thyroid transcription factors may 
contribute to the disappearance of the thyroid primordium; the higher incidence of thyroid 
loss observed in the embryos lacking nk2.1a or hhex or pax2a (Elsalini et al., 2003) 
compared to that observed in this experiment is explainable with the hypothesis that other 
proteins regulated by thyroid transcription factors could cooperate with bcl2l to ensure the 
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correct thyroid development. In support of this hypothesis bcl2l mRNA was found not able 
to rescue the thyroid phenotype, when it was injected in combination with nk2.1a or hhex 
MO, suggesting that other factors relevant for thyroid development are absent in the 
morphant embryos. It is important also to keep in mind that bcl2-MO injection causes high 
rate of embryo lethality and so the percentage of embryos showing the thyroid phenotype 
could be higher than that measured.  
The role of Bcl2 during mouse thyroid development has not been investigated. Studies 
on knock-out mice for Bcl2 have been reported from different groups (Kamada et al., 1995; 
Nakayama et al., 1994; Veis et al., 1993) showing growth retardation, polycystic kidney 
disease, lymphocytopenia and hypopigmented hair, but no one has reported analysis of 
thyroid development. From studies on Pax8 knock-out mice it is known that the absence of 
thyroid leads to death within three weeks after birth (Friedrichsen et al., 2003; Mansouri et 
al., 1998). Mice lacking Bcl2 activity are smaller than the control littermate and a high 
percentage of them dies in 2-3 weeks (Kamada et al., 1995; Nakayama et al., 1994; Veis et 
al., 1993), suggesting that thyroid development could be impaired in these mice. The living 
animals at 3 week survive also longer than 10 weeks. This phenotype is coherent with the 
heterogeneous thyroid phenotype observed in zebrafish morphant embryos for bcl2l.  
  
Table 3 Statistics of bcl2l-MO phenotype 
Genotype/Phenotype 
Embryos with  
normal thyroid 
signal 
Embryos 
with smaller 
thyroid signal 
Embryos with 
no thyroid 
signal 
TOT 
pax2a 
bcl2l MO      56 (43%) 38 (29,2%) 36 (27,7%) 130 
bcl2l MO + mRNA 76 (72,4%) 24 (22,9%) 5 (4,8%) 105 
control MO 100 (80%) 22 (17,6%) 3 (2,4) 125 
pax8 
bcl2l MO 46 (28,9%) 67 (42,1%) 46 (28,9%) 159 
bcl2l MO + mRNA 77 (70,6%) 27 (24,8%) 5 (4,6%) 109 
control MO 100 (82,6%) 21 (17,4%) 0 121 
nk2.1a 
bcl2l MO 22 (30,5%) 35 (48,6%) 15 (20,8%) 72 
bcl2l MO + mRNA 64 (64%) 35 (35%) 1 (1%) 100 
control MO 42 (60%) 24 (34,3%) 4 (5,7) 70 
Hhex 
bcl2l MO 34 (41%) 27 (32,9%) 21 (25,6%) 82 
bcl2l MO + mRNA 56 (71%) 22 (27,8%) 1 (1,2%) 79 
control MO 85 (90,4%) 9 (9%) 0 94 
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Figure 31 Foregut endoderm of bcl2l 
morphant embryos. Lateral views with 
anterior to the top of 48 hpf embryos 
stained for the endodermal marker foxa3 
are shown. Genotype is indicated bottom 
left and staining/marker top right. Pa, 
pharyngeal endoderm.  
 
 
Analysis of apoptosis during thyroid degeneration in manipulated 
embryos 
Bcl2l is positively regulated by the thyroid transcription factors hhex, nk2.1a and 
pax2a; down-regulation of these factors leads to loss of bcl2l thyroid expression and then 
to thyroid disappearance. Considering the anti-apoptotic function of bcl2l, it could be 
supposed that thyroid degenerates, in manipulated embryos, by means of apoptotic 
processes.   
To test this hypothesis the activation of caspase-3, an effector caspase that plays a 
crucial role in the apoptotic cascade, was analyzed in embryos injected with 2,5 ng of 
nk2.1a-MO or with 1,4 ng of hhex-MO using a specific antibody for active-caspase-3, by 
means of WMIHC. The morphant embryos were analyzed at three different developmental 
stage, 45, 50 and 60 hpf, considering that the thyroid primordium disappears between 48 
and 60 hpf. The apoptosis level, measured as caspase-3 activation, was found to be 
increased in thyroid region of knocked-down embryos compared to embryos injected with 
2,5 ng of control-MO (Table 4); in particular, the higher number of embryos showing 
positive active-caspase-3 cells in thyroid region is observed at 50 hpf.   
Table 4 Apoptosis incidence in the region of thyroid primordium in hhex and nk2.1a morphant 
embryos 
developmental stage / 
genotype 
hhex-MO nk2.1a-MO ctrl-MO 
45 hpf 25,7% (9/35) 25,8% (8/31) 11,8% (4/34) 
50 hpf 49% (25/51) 51,8% (14/27) 5% (1/20) 
60 hpf 45,2% (19/42) 27,3% (9/33) 6,9% (2/29) 
 
To verify if the observed apoptotic cells were localized in thyroid primordium, 
morphant embryos for nk2.1a-MO were co-stained for hhex via ISH and active-caspase-3 
via IHC. Active-caspase-3 positive cells were found in correspondence of hhex positive 
cells in 21 embryos of 129 analyzed (16%) (Figure 32 B); in the control-MO injected 
embryos no active-caspase-3 positive cells were found overlapping with thyroid cells 
(Figure 32 A). The occurrence of active-caspase-3 positive cells in the region of thyroid 
primordium is indicative that the apoptotic process takes an active role in thyroid 
degeneration in absence of nk2.1a transcription factor. 
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The same experiment was 
performed on bcl2l morphant 
embryos; active-caspase-3-positive 
cells overlapping with hhex-positive 
cells were observed in 15 of 125 
(12%) morphant embryos (Figure 33 
B) compared to 2 of 110 of control-
MO injected embryos (Figure 33 A). 
The presence of active-caspase-3 
signal in thyroid primordium of 
bcl2l morphant embryos suggests 
that this factor performs its 
antiapoptotic function during 
thyroid development.  
The finding that active-caspase-
3 positive cells are increased in 
number in thyroid region of 
embryos lacking nk2.1a or hhex 
and/or the antiapoptotic factor bcl2l 
is the first direct index that caspase-
dependent apoptosis plays a role in 
thyroid degeneration in the embryos 
deprived of thyroid transcription 
factors and that apoptotic processes 
are prevented during normal thyroid 
development by the antiapoptotic 
factor bcl2l. 
These result do not permit to 
exclude the possibility that bcl2l 
functions during thyroid 
development also by mechanisms 
other than the only prevention of 
the classical caspase-mediated apoptosis. Indeed, it has been documented by in vitro and in 
vivo experiment that programmed cell death can occur also in absence of caspase 
activation and that this mechanism, called caspase-independent cell death, is really diffuse 
(Constantinou et al., 2009). The stimuli inducing caspase-independent cell death are not 
necessarily different from those inducing caspase-dependent cell death and the two 
pathways may be activated simultaneously. Furthermore, many events that take place in 
caspase-dependent cell death are also involved in caspase-independent cell death; this is 
the case of Bcl2 that is able to prevent also the caspase-independent cell death (Okuno et 
al., 1998). The possibility that, in our experimental model, thyroid degeneration occurs via 
both cell death mechanisms and that bcl2l is involved in regulating both mechanism 
remains still open. Furthermore, simultaneously persistence of both mechanisms could 
explain why the incidence of active-caspase-3-positive cells observed in thyroid 
primordium is lower than the incidence of thyroid disappearance in morphant embryos.     
Another still open question is whether bcl2l is able to impact on thyroid development using 
a mechanism different from apoptosis. Indeed, in a variety of experimental models it has 
been demonstrated that antiapoptotic Bcl2 family genes have a role in regulating processes 
Figure 32 Detection of apoptotic cells in nk2.1a morphant 
embryos. Lateral views with anterior to the top of 50 hpf embryos 
are shown. Genotype is indicated bottom left, percentage 
(indicating the incidence of apoptotic cells overlapping with thyroid 
cells) bottom right and staining/markers top right. Thyroid cells are 
stained with hhex-probe via ISH and apoptotic cells are stained with 
active-caspase-3-antibody via IHC. Arrow points to active-caspase-3 
positive cells in thyroid primordium. 
 
Figure 33 Detection of apoptotic cells in bcl2l morphant embryos. 
Lateral views with anterior to the top of 42 hpf embryos are shown. 
Genotype is indicated bottom left, percentage (indicating the 
incidence of apoptotic cells overlapping with thyroid cells) bottom 
right and staining/markers top right. Thyroid cells are stained with 
hhex-probe via ISH and apoptotic cells are stained with active-
caspase-3-antibody via IHC. Arrow points to active-caspase-3 
positive cells in thyroid primordium. 
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beyond their function as antiapoptotic molecules: mouse Bcl2 promotes differentiation and 
activity beyond that survival of both osteoblasts and osteoclasts (Nagase et al., 2009); it is 
involved in determining chondrocytes phenotype, probably by regulating SOX9, a 
transcription factor necessary for expressing the major cartilage matrix proteins (Kinkel 
and Horton, 2003); Bcl2 plays also a role in regulating axonal growth rate and regeneration 
in mouse embryonic neurons (Chen et al., 1997; Hilton et al., 1997); the zebrafish bcl-2 
homologue nrz contributes to cell movements during gastrulation by negatively regulating 
the expression of Snail-1, a transcription factor that controls cell adhesion (Arnaud et al., 
2006). Our data indicate that bcl2l down-regulation causes impairment in thyroid 
development but do not permit to exclude that this could happen also via a mechanism 
independent from the apoptotic one. 
 
45 
 
5. Conclusions  
The experimental work presented in this thesis has led to the acquisition of new 
information on thyroid evolution and development. 
 Conservation of the known mechanisms underlying thyroid development and function 
in mouse and zebrafish prompted to perform a comparative analysis in zebrafish of new 
data on mouse thyroid bud transcriptome. The low correspondence in thyroid expression 
profile observed in the two experimental models strongly suggests that molecular changes 
in thyroid morphogenesis occurred during the transition from lower to higher vertebrates, 
but after that the biochemistry of thyroid function was conquered in evolution. In 
particular, the high number of genes expressed in mouse thyroid bud and not found in 
zebrafish thyroid bud could represent newly acquired functions by the thyroid tissue during 
the vertebrates lineage. Hence, from an evolutionary point of view, the scattered thyroid 
follicles in zebrafish could be considered, morphologically and molecularly, one step in the 
progressive rearrangement of the pharyngeal area that, starting from the invertebrate 
endostyle precursor has conduced to the mammalian gland.  
Even if molecular changes have modified the capacity of thyroid cells to shape the 
mammalian gland, the key molecular factors relevant for thyroid cells identity and 
maintenance are clearly conserved. This is the case of the thyroid transcription factors and 
of the new function identified in thyroid in both mouse and zebrafish. The work presented 
here demonstrates that an antiapoptotic function present in mouse thyroid primordium was 
already present in fish, suggesting its essential role for thyroid development independently 
from the molecular divergence occurred during thyroid evolution. In zebrafish, bcl2l is 
expressed in thyroid bud since early steps of development; its thyroid transcription is finely 
regulated by the transcription factors nk2.1a, pax2a and hhex, each one necessary but not 
sufficient to achieve normal bcl2l thyroid expression. This tight synergic regulation is 
index that bcl2l transcription is essential for thyroid development; in fact, down-regulation 
of bcl2l leads to severe impairments in normal thyroid development probably due to the 
loss of its antiapoptotic function. Considering that an antiapoptotic factor of Bcl2 gene 
family is expressed also in mouse thyroid bud, it is likely that also in human, thyroid 
development requires this function and that its impairment leads to congenital 
hypothyroidism.      
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8. Appendix  
Table 5 Gene enriched in mouse thyroid bud (E10) with a fold change  10.  
Mouse 
Gene 
symbol 
Gene title Gene 
symbol 
Zebrafish 
ortholog  
Ensembl 
gene  ID  
Zebrafish 
ortholog 
Clone 
availability 
24 - 28 hpf 42 -48 hpf 72 hpf 96 hpf 
4930426D
05Rik 
RIKEN cDNA 
4930426D05 gene 
--- 
 
 
    
Iigp1-
LOC10004
4196 
interferon inducible 
GTPase 1 
irgf3 - 
LOC797731 
ENSDARG00
000062820 
Cloned 
Ubiquitous (high level) Ubiquitous (low 
level) - CNS (central 
nervous system) 
(high level) 
Ubiquitous (low 
level) 
Ubiquitous (low 
level) 
  LOC563833 ENSDARG00
000062828 
--- --- --- --- --- 
  A3QJW3_DA
NRE 
ENSDARG00
000070772 --- 
--- --- --- --- 
  irgf1  ENSDARG00
000070774 
--- --- --- --- --- 
  IRGC (4 of 
10)  
ENSDARG00
000078453 --- 
--- --- --- --- 
  LOC565002  ENSDARG00
000014975 Cloned 
Ubiquitous (high level) Ubiquitous (low 
level) - CNS (high 
level) 
Ubiquitous (low 
level) 
Ubiquitous (low 
level) 
  LOC1000075
13 
ENSDARG00
000060910 Cloned 
 
 
Ubiquitous (low 
level) - CNS (high 
level) 
Ubiquitous (low 
level) 
Ubiquitous (low 
level) 
  IRGC (9 of 
10) - 
LOC571560  
ENSDARG00
000067617 --- 
--- --- --- --- 
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  irgq2  ENSDARG00
000068657 
--- --- --- --- --- 
  irge4  ENSDARG00
000070317 IRBOp991D0
896D 
CNS 
(rhombencephalon, 
cerebellum, 
tegmentum) 
CNS 
(rhombencephalon, 
cerebellum, 
tegmentum) 
No expression No expression 
Bcl2 B-cell 
leukemia/lymphom
a 2 
bcl2 ENSDARG00
000025613 IRAKp961L0
9304Q 
Pronephric ducts - CNS 
- otic placode 
Pronephric ducts - 
CNS - otic placode 
No expression No expression 
Prlr prolactin receptor prlra  ENSDARG00
000016570 Cloned 
Pronephric ducts - 
pancreatic bud 
Pronephric ducts - 
pancreatic bud 
Pronephric 
ducts - 
pancreatic bud 
Pronephric 
ducts - 
pancreatic bud 
  prlrb  ENSDARG00
000045955 Cloned 
Pronephric ducts Pronephric ducts Pronephric 
ducts 
Pronephric 
ducts 
Cpne4 copine IV si:dkey-
5n4.1 
ENSDARG00
000062754 Cloned 
Olfactory placodes Olfactory placodes Olfactory 
placodes 
Olfactory 
placodes 
  Q1LYM2_DA
NRE  
ENSDARG00
000040069 --- 
--- --- --- --- 
Ptpre protein tyrosine 
phosphatase, 
receptor type, E 
NP_0010386
42.1  
ENSDARG00
000021151 Cloned 
CNS - ventral somites CNS - heart CNS No expression 
  LOC567443  ENSDARG00
000015891 
Cloned No expression CNS - eyes - liver CNS No expression 
  Transcribed locus        
Hivep3 human 
immunodeficiency 
virus type I 
enhancer binding 
protein 3 
HIVEP3 (1 of 
2)  
ENSDARG00
000037154 
IMAGp998G
0819851Q 
No expression No expression No expression CNS 
  A5PMB4_DA
NRE  
ENSDARG00
000075928 --- 
--- --- --- --- 
Nptx1 neuronal pentraxin 
1 
zgc:85889  
ENSDARG00
IRAKp961F0
8239Q 
otic vesicles CNS - heart - otic 
vesicles 
CNS - pharynx CNS - pharynx 
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000030735 - 
ENSDARG00
000074671  
  si:dkey-
14o18.2 
ENSDARG00
000062995 --- 
--- --- --- --- 
Irs4 insulin receptor 
substrate 4 
IRS4 ENSDARG00
000052065 --- 
--- --- --- --- 
2310010M
24Rik 
RIKEN cDNA 
2310010M24 gene 
lypd6b  ENSDARG00
000057226 
Cloned 
CNS - otic vesicles - 
pronephric ducts - tail - 
olfactory placodes 
CNS - otic vesicles - 
olfactory placodes - 
heart 
CNS - otic 
vesicles - 
olfactory 
placodes - heart 
CNS - otic 
vesicles - 
olfactory 
placodes - heart 
1600029D
21Rik 
RIKEN cDNA 
1600029D21 gene 
--- 
 
 
    
Matn2 matrilin 2 matn4  ENSDARG00
000015947 
IRALp962J02
64Q 
pharyngeal arches - 
posterior blood island - 
primitive 
hematopoietic cells - 
otic vesicles - 
pronephric duct - 
retina 
caudal fin - dorsal fin 
- pectoral fin - 
posterior blood 
island - otic vesicles - 
retina 
somites - retina 
- pharynx - 
pectoral fin 
pectoral fin - 
gut- neuromast 
Bcl11b B-cell 
leukemia/lymphom
a 11B 
A2CE94_DA
NRE 
ENSDARG00
000062510 
Cloned 
 
CNS (optic tectum - 
tegmentum - 
cerebellum - 
rhombencephalon) 
CNS (optic tectum - 
tegmentum - 
cerebellum - 
rhombencephalon) - 
heart region 
CNS (optic 
tectum - 
tegmentum - 
cerebellum - 
rhombencephal
on) - heart 
region 
CNS 
  LOC1000005
03  
ENSDARG00
000067727 
Cloned 
CNS (optic tectum - 
diencephalon - 
cerebellum - 
rhombencephalon) 
CNS (optic tectum - 
diencephalon - 
cerebellum - 
rhombencephalon) 
CNS (optic 
tectum - 
diencephalon - 
cerebellum - 
rhombencephal
on) 
CNS 
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Klhl14 kelch-like 14 
(Drosophila) 
LOC794722  ENSDARG00
000045275 Cloned 
CNS (cerebellum ) - 
optic nerve 
CNS (cerebellum - 
rhombencephalon) - 
optic nerve 
CNS CNS 
Clstn2 calsyntenin 2 clstn2  ENSDARG00
000060637 
Cloned CNS - epithelial cells CNS CNS - gut CNS 
  LOC569664  ENSDARG00
000060638 Cloned 
CNS (telencephalon) CNS - olfactory 
placodes - heart 
Olfactory 
placodes - heart 
Olfactory 
placodes 
Stc2 stanniocalcin 2 stc2 ENSDARG00
000056680 
IMAGp998E
1314597Q 
Pituitary gland Pituitary gland - 
pectoral fin 
Pituitary gland - 
pectoral fin 
Pituitary gland - 
pectoral fin 
  LOC558195  IMAGp998E
0315213Q 
Pharyngeal arches Pharyngeal arches Pharyngeal 
arches 
Pharyngeal 
arches 
Cpxm2 carboxypeptidase X 
2 (M14 family) 
LOC797452  ENSDARG00
000078792 --- 
--- --- --- --- 
Slc4a5 solute carrier 
family 4, sodium 
bicarbonate 
cotransporter, 
member 5 
A2BIJ8_DAN
RE  
ENSDARG00
000002771 
--- 
--- --- --- --- 
  SLC4A5 (2 of 
2) 
ENSDARG00
000005966 --- 
--- --- --- --- 
Chdh choline 
dehydrogenase 
CHDH ENSDARG00
000075162 
 
Cloned 
Somites - pronephric 
ducts 
Liver - gut - thyroid 
region - pronephric 
ducts 
Liver - gut Live - gut 
Ctxn3 cortexin 3 CTXN3  ENSDARG00
000033508 
--- --- --- --- --- 
  wu:fj35c01 ENSDARG00
000075413 
--- --- --- --- --- 
5730414M
22Rik 
RIKEN cDNA 
5730414M22 gene 
/ Kcnma1 
NP_0011390
72.1 
ENSDARG00
000079840 --- 
--- --- --- --- 
Cd44 CD44 antigen        
Hexb hexosaminidase B zgc:112084  ENSDARG00
000052113 
IRBOp991F1
1111D 
No expression No expression No expression No expression 
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  hexa  ENSDARG00
000034368 
IRBVp5006B
1013D 
Eyes ubiquitous (in 
particular pronephric 
ducts - 
hematopoietic cells - 
CNS -pharynx) 
Eyes Gut 
Htra1 HtrA serine 
peptidase 1 
zgc:172061 ENSDARG00
000014907z --- 
--- --- --- --- 
  htra1  ENSDARG00
000032831 IRBOp991C0
443D 
Lens - tail Heart Bulbus 
arteriosus  - 
thyroid region 
Bulbus 
arteriosus 
Gcgr glucagon receptor LOC565237  ENSDARG00
000036272 
--- --- --- --- --- 
  LOC562973 ENSDARG00
000070973 
Cloned Pancreatic bud No expression Gut - liver No expression 
Elfn1 leucine rich repeat 
and fibronectin 
type III, 
extracellular 1 
ENSDARG00
000073889 
ENSDARG00
000073889 
Cloned 
CNS CNS CNS CNS 
  sc:d0369  ENSDARG00
000074372 
--- --- --- --- --- 
  LOC562570  ENSDARG00
000078141 
Cloned CNS CNS CNS CNS 
Scara5 scavenger receptor 
class A, member 5 
si:ch211-
200p13.4  
ENSDARG00
000010425 --- 
--- --- --- --- 
Zbtb20 zinc finger and BTB 
domain containing 
20 
zgc:158317  ENSDARG00
000005586 IRBOp991C1
178D 
No expression CNS CNS (low level) CNS (low level) 
5033414K0
4Rik 
RIKEN cDNA 
5033414K04 gene 
pid1 ENSDARG00
000040315 
IRBVp5006D
118D 
CNS CNS CNS - thyroid 
region 
CNS (low level) 
Moxd1 monooxygenase, 
DBH-like 1 
moxd1 ENSDARG00
000031136 --- 
--- --- --- --- 
  moxd1l  ENSDARG00
000069296 
IMAGp998M
0615143Q 
Ubiquitous (low level) Olfactory placodes Ubiquitous (low 
level) - olfactory 
No expression 
61 
 
placodes (high 
level) 
Vldlr very low density 
lipoprotein 
receptor 
vldlr  ENSDARG00
000006257 IRBOp991F0
216D 
CNS CNS CNS CNS 
Afap1l2 actin filament 
associated protein 
1-like 2 
AFAP1L2  ENSDARG00
000074806 --- 
--- --- --- --- 
Tcfcp2l1 transcription factor 
CP2-like 1 
tfcp2l1 ENSDARG00
000029497 
IMAGp998L1
014682Q 
Pituitary gland Pituitary gland Gut Liver - gut 
  si:ch211-
207c15.3  
ENSDARG00
000018000 
IRBOp991D0
7105D 
CNS CNS CNS CNS 
  sich211-
210c8.8 
ENSDARG00
000060306 Cloned 
CNS CNS Pharynx, 
swimming 
bladder 
No expression 
  Transcribed locus ---       
Socs2 suppressor of 
cytokine signaling 2 
socs2  ENSDARG00
000045557 Cloned 
Ubiquitous (low level) Ubiquitous (low 
level) 
Ubiquitous (low 
level) 
CNS - eyes 
Ryr3 ryanodine receptor 
3 
ryr3  ENSDARG00
000042531 
IMAGp998H
1219257Q 
Somites Somites Somites Somites 
Corin Corin B0V3M2_DA
NRE 
ENSDARG00
000063640 --- 
--- --- --- --- 
  Transcribed locus ---       
Calml3 calmodulin-like 3 Calm3a ENSDARG00
000037014 IRBOp991G0
338D 
Eyes - CNS - pronephric 
ducts - cloaca - somites 
Eyes - CNS - 
pronephric ducts - 
cloaca - somites 
CNS CNS - gut - eyes 
Galns galactosamine (N-
acetyl)-6-sulfate 
sulfatase 
galns ENSDARG00
000051853 IRBOp991E0
878D 
Ubiquitous (high level) Epidermal cells CNS Pharyngeal 
arches - 
olfactory 
placodes 
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Table 6 Gene enriched in thyroid and in lung buds (E10) with a fold change  10. 
Mouse 
Gene 
symbol 
Gene title Gene 
symbol 
Zebrafish 
ortholog  
Ensembl 
gene  ID  
Zebrafish 
ortholog 
Clone 
availability 
24 - 28 hpf 42 -48 hpf 72 hpf 96 hpf 
Sorl1 sortilin-related 
receptor 
SORL1 ENSDARG00
000013892 
Cloned  No expression No expression No expression No expression 
Rassf10 Ras association 
(RalGDS/AF-6) 
domain family (N-
terminal) member 
10 
RASSF10 (1 
of 2)  
ENSDARG00
000074159 
--- 
--- --- --- --- 
Prss8 protease, serine, 8 
(prostasin) 
zgc:92313 ENSDARG00
000040513 
--- 
--- --- --- --- 
  LOC1000015
20 
ENSDARG00
000027196 
--- 
--- --- --- --- 
  zgc:101788 ENSDARG00
000055644 
Cloned  Olfactory placodes Olfactory placodes Olfactory 
placodes 
Olfactory 
placodes 
Adrbk2 adrenergic receptor 
kinase, beta 2 
adrbk2  ENSDARG00
000013007 
IMAGp998N
0614836Q  CNS CNS - heart CNS CNS - gut 
1810019J1
6Rik 
RIKEN cDNA 
1810019J16 gene 
LOC797923 ENSDARG00
000079834 
IMAGp998M
2115687Q  
No expression  Pharynx (low level) Ubiquitous Ubiquitous  
  LOC1001508
62 
ENSDARG00
000069522 
IMAGp958O
243308Q  Posterior region of CNS 
Posterior region of 
CNS Eyes Gut 
Spint1 serine protease 
inhibitor, Kunitz 
type 1 
spint1b ENSDARG00
000012467 IRAKp961D1
2311Q  
No expression No expression No expression No expression 
  spint1a/spin
t1l 
ENSDARG00
000023673 
IRBOp991A0
44D  
Pectoral fins - 
epidermal cells - otic 
Pectoral fins - 
epidermal cells - otic 
pharyngeal 
region 
pharyngeal 
region - liver  
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vesicles vesicles -pharynx 
Ltbp3 latent transforming 
growth factor beta 
binding protein 3 
A2BFE2_DA
NRE 
ENSDARG00
000035682 
IMAGp998E
0914796Q 
Heart - thyroid region Heart - thyroid region Heart - thyroid 
region 
no expression 
Sorbs2 sorbin and SH3 
domain containing 
2 
B8JIG0_DAN
RE  
ENSDARG00
000003046 
--- 
--- --- --- --- 
  B8A438_DA
NRE  
ENSDARG00
000061603 
Cloned  Somites - rombomers - 
heart  
CNS - heart - eyes - 
somites 
Eyes - heart Eyes - heart - 
CNS 
Pla2g7 phospholipase A2, 
group VII (platelet-
activating factor 
acetylhydrolase, 
plasma) 
zgc:77563 ENSDARG00
000003584 
IRBOp991A0
137D  
Lens  Lens  No expression   No expression 
  zgc:153597 ENSDARG00
000002981 
IRBOp991A0
285D  
No expression Epidermal cells  No expression CNS 
Slc16a2 solute carrier family 
16 (monocarboxylic 
acid transporters), 
member 2 
si:ch211-
241j12.1 
ENSDARG00
000020984 
IRBOp991D1
178D 
Blood cells Caudal fin - liver - 
pectoral fin - 
pharyngeal region - 
blood island 
Heart - liver - 
pectoral fin 
Heart - liver - 
pectoral fin 
Dsg2 desmoglein 2 ENSDARG00
000039665 
ENSDARG00
000039665 
--- 
--- --- --- --- 
  ENSDARG00
000062750 
ENSDARG00
000062750 
--- 
--- --- --- --- 
  LOC571042 ENSDARG00
000076426 
IMAGp998M
0714816Q  
heart region - thyroid 
region 
heart region - thyroid 
region 
Heat - gut CNS - gut 
  ENSDARG00
000076945 
ENSDARG00
000076945 
IMAGp958O
023217Q 
Pectoral fins - olfactory 
placodes - pharyngeal 
endoderm 
Pectoral fins - 
pharynx - ventral 
caudal fin 
Pharynx Pharynx 
Grina glutamate receptor, 
ionotropic, N-
methyl D-aspartate-
associated protein 1  
zgc:64102 ENSDARG00
000052746 
IMAGp998J1
614304Q 
CNS Ubiquitous (low 
level) - CNS (high 
level) 
CNS CNS 
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  zgc:136572 ENSDARG00
000023262 
IMAGp998B
0215589Q 
CNS No expression Ubiquitous (low 
level) 
CNS 
Marveld2 MARVEL 
(membrane-
associating) domain 
containing 2 
Q32PL4_DA
NRE 
ENSDARG00
000025076 
Cloned  Ubiquitous  Ubiquitous  Ubiquitous  Ubiquitous  
  marveld2b ENSDARG00
000061651 
IRALp962I09
64Q  Ubiquitous  Heart Pharynx Pharynx - CNS 
  B0UXT0_DA
NRE 
ENSDARG00
000061800 
--- 
--- --- --- --- 
Egfl6 EGF-like-domain, 
multiple 6 
EGFL6  ENSDARG00
000045958 
IRBOp991D0
675D  
Somites - pharyngeal 
endoderm - hindbrain - 
caudal fin 
Pharynx - pectoral 
fins - caudal fin 
Pharynx Ubiquitous (low 
level) 
  NP_0011390
52.1 
ENSDARG00
000018721 
--- 
--- --- --- --- 
Zbtb4 zinc finger and BTB 
domain containing 
4 
Q06Z31_DA
NRE 
ENSDARG00
000061827 
IMAGp998J1
210761Q 
Diencephalon - 
hindbrain mindbrain 
boundary - thyroid 
region 
Thyroid region - CNS CNS - heart - 
region of 
thyroid follicles 
CNS 
EG432995 predicted gene, 
EG432995 
--- 
       
Atp10a ATPase, class V, 
type 10A 
LOC567172  ENSDARG00
000061039 
IMAGp998O
1712421Q 
No expression No expression No expression No expression 
  NP_0011390
79.1 
ENSDARG00
000078887 
 
--- --- --- --- 
Cdh1 cadherin 1 cdh1 ENSDARG00
000024371 
Cloned  Epidermis - pronephric 
ducts - olfactory 
placodes   
Pharynx  Pharynx  Pharynx 
  LOC567602  ENSDARG00
000035796 
IMAGp998P
2015688Q  Heart Heart No expression Pharynx 
  si:busm1-
71b9.2  
ENSDARG00
000068142 
--- 
--- --- --- --- 
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  si:busm1-
180o5.1  
ENSDARG00
000068137 
--- 
--- --- --- --- 
Prkar1b protein kinase, 
cAMP dependent 
regulatory, type I 
beta 
zgc:153624 ENSDARG00
000062926 
IRBOp991D0
586D  
Hindbrain  Hindbrain  Hindbrain  Hindbrain  
St14 suppression of 
tumorigenicity 14  
st14b/zgc:15
2947 
ENSDARG00
000044655 
IRBOp991C0
583D  
No expression   No expression   No expression   No expression   
  st14a ENSDARG00
000061173 
IRBOp991G0
283D  
Cloaca -olfactory 
placodes - otic vesicles 
- epidermis  
pharyngeal pouches 
CNS - pharynx Pharynx Pharynx 
  LOC557248 ENSDARG00
000060754 
IMAGp998E
0919186Q  
Pharynx - epidermis Pharynx - pectoral 
fins - caudal fins 
Posterior 
pharynx 
Pharynx - gut  
Tmem176
a 
transmembrane 
protein 176A 
ENSDARG00
000074390 
ENSDARG00
000074390 
--- 
--- --- --- --- 
  LOC1000072
21 
ENSDARG00
000018671 
--- 
--- --- --- --- 
  NP_0011390
82.1 
ENSDARG00
000078659 
--- 
--- --- --- --- 
BC034069 cDNA sequence 
BC034069 
--- 
       
Lonrf3 LON peptidase N-
terminal domain 
and ring finger 3 
--- 
       
H6pd hexose-6-
phosphate 
dehydrogenase  
LOC569348 ENSDARG00
000060153 
IMAGp998P
228992Q  
No expression   No expression   No expression   No expression   
D630039A
03Rik 
RIKEN cDNA 
D630039A03 gene 
zgc:171750 ENSDARG00
000078638 
--- 
--- --- --- --- 
 Transcribed locus        
Kcnk1 potassium channel, NP_0011390 ENSDARG00
000017254 IMAGp998F
No expression No expression CNS (low level) CNS (low level) 
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subfamily K, 
member 1 
47.1 0911846Q 
  zgc:165664 ENSDARG00
000045067 
IRBOp991A0
5104D  
Hindbrain  No  expression CNS (low level) CNS (low level) 
Slco2a1 solute carrier 
organic anion 
transporter family, 
member 2a1 
slco2a1  ENSDARG00
000061896 
IRBOp991H1
097D  
No  expression No expression No expression CNS 
  zgc:123236  ENSDARG00
000054609 
IRBOp991C0
372D  
Pharyngeal arches Pharyngeal arches Pharyngeal 
arches  
No expression 
Eppk1 epiplakin 1 eppk1  IMAGp998O
1710281Q 
pharyngeal endoderm - 
heart - first pair of 
branching arteries 
Pharynx Pharynx - 
pharyngeal 
arches - 
pronephric 
ducts - gut 
Pharynx - gut 
Rnf128 ring finger protein 
128 
rnf128 ENSDARG00
000016867 
IMAGp998G
0414808Q 
Olfactory placodes - 
pectoral fins - pharynx 
posterior pharynx- 
liver 
Gut  No expression 
  ENSDARG00
000029890 
ENSDARG00
000029890 --- --- --- --- --- 
Cldn7 claudin 7 cldn7  ENSDARG00
000014047 
IRBOp991C1
217D  
Epidermis - pronephric 
ducts - olfactory 
placodes - lateral line 
primordium - otic 
vesicles 
Epidermis - 
pronephric ducts - 
olfactory placodes - 
lateral line 
primordium - otic 
vesicles - pharyngeal 
endoderm 
Lateral line - 
pharynx - ear - 
nose - pectoral 
fin - pronephric 
ducts  
Lateral line - 
pharynx - ear - 
nose - pectoral 
fin - pronephric 
ducts 
  zgc:92192 ENSDARG00
000036376 
--- --- --- --- --- 
Nbeal2 neurobeachin-like 2 NBEAL2 (1 of 
2) 
ENSDARG00
000032436 
--- 
--- --- --- --- 
  NBEAL2 (2 of 
2) 
ENSDARG00
000044955 
--- 
--- --- --- --- 
Spint2 serine protease zgc:153795  ENSDARG00 IRBOp991C0 otic vesicle - Pharynx -  cloaca - Pharynx Pharynx 
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inhibitor, Kunitz 
type 2 
000069476 692D  pronephric ducts olfactory placodes - 
pronephric ducts 
  si:dkey-
61p9.9 
ENSDARG00
000068873 
--- 
--- --- --- --- 
Tle2 transducin-like 
enhancer of split 2, 
homolog of 
Drosophila E(spl) 
Q1MT48_DA
NRE 
ENSDARG00
000008767 
--- 
--- --- --- --- 
  si:ch211-
81i17.1 
ENSDARG00
000042484 
Cloned  CNS CNS CNS CNS 
Marveld3 MARVEL 
(membrane-
associating) domain 
containing 3 
si:ch211-
191a24.4 
ENSDARG00
000037528 
IRBVp5006C
1213D  
No expression  Pharynx - cloaca Pharynx  Pharynx  
  zgc:66450  ENSDARG00
000026011 
IRBOp991C0
19D  
No expression  No expression  No expression  No expression  
Tbx3 T-box 3 Tbx3b ENSDARG00
000002216 
IRBOp991D0
491D  
otic vesicles - eyes Otic vesicles - eyes - 
pectoral fin 
Eyes  No expression 
  LOC568479 
similat to 
Txb 3b 
ENSDARG00
000061509 
--- 
--- --- --- --- 
Slc44a3 solute carrier family 
44, member 3 
B8A445_DA
NRE 
ENSDARG00
000015946 
IMAGp998J1
815677Q 
Ubiquitous ubiquitous (high 
level) 
ubiquitous CNS 
  LOC571619    --- --- --- --- --- 
Epb4.1l4b erythrocyte protein 
band 4.1-like 4b 
LOC407635  ENSDARG00
000061398 
--- 
--- --- --- --- 
  epb4.1l4  ENSDARG00
000040087 
IRAKp961M
14136Q  
CNS (hindbrain) CNS - lens CNS (low level) No expression 
  epb41l5  ENSDARG00
000032324 
IRBOp991H0
237D  
CNS (low level) - eyes - 
olfactory placodes 
No expression CNS (low level) No expression 
Map3k5 mitogen-activated 
protein kinase 
map3k5 ENSDARG00
000005416 
IMAGp998C
208948Q  
CNS - somites CNS - somites CNS - pharynx Pharynx 
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kinase kinase 5 
Cldn3 claudin 3 LOC792492  ENSDARG00
000041504 
--- --- --- --- --- 
  cldnh  ENSDARG00
000069503 
IRBOp991E0
34D 
 
Pituitary gland - 
pronephric ducts - 
olfactory placodes 
Pituitary gland - 
olfactory placodes  
Olfactory 
placodes 
Olfactory 
placodes 
Cdh16 cadherin 16 CDH16  ENSDARG00
000077570 
Cloned  Corpuscles of Stannius Corpuscles of 
Stannius 
Corpuscles of 
Stannius 
Corpuscles of 
Stannius 
  si:busm1-
71b9.3 
ENSDARG00
000051843 
--- 
--- --- --- --- 
Arhgef16 Rho guanine 
nucleotide 
exchange factor 
(GEF) 16 
NP_0011167
55.1  
ENSDARG00
000077114 
--- 
--- --- --- --- 
Rbm35b RNA binding motif 
protein 35b 
rbm35b  ENSDARG00
000018814 
IRBOp991E0
315D  
olfactory placodes -
pronephric ducts - otic 
placodes - pharynx - 
liver 
otic placodes - 
pharynx - liver 
pharynx Gut 
Capg capping protein 
(actin filament), 
gelsolin-like 
 capg  ENSDARG00
000021318 
--- 
--- --- --- --- 
  B0R0M1_DA
NRE 
ENSDARG00
000035560 
--- 
--- --- --- --- 
Hpn hepsin  si:dkey-
33i11.3 
ENSDARG00
000027609 
IRBOp991C0
393D  
ubiquitous (low level) ubiquitous (low level) ubiquitous (low 
level) 
Gut 
BC031353 cDNA sequence 
BC031353 
si:dkey-
266j9.3 
ENSDARG00
000040452 
IRAKp961O1
6284Q  
CNS - somites CNS - pectoral fin - 
thyroid region 
CNS CNS - gut - 
pharynx  
  A2CEB6_DA
NRE 
ENSDARG00
000068650 
--- 
--- --- --- --- 
Cckar cholecystokinin A 
receptor 
LOC569038  ENSDARG00
000052089 
IMAGp998M
1117138Q  
Somites Somites - pectoral 
fins 
Somites - heart - 
pectoral fin - 
pharyngeal 
arches 
Somites - 
pectoral fins- 
CNS - 
pharyngeal 
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arches 
Meg3 maternally 
expressed 3 --- 
 
 
    
Tapbp TAP binding protein tpsn ENSDARG00
000036803 
IRBOp991A0
8107D  
No expression No expression No expression No expression 
  tpsn 
(si:ch211-
51f10.1) 
ENSDARG00
000045011 --- --- --- --- --- 
Rgs17 regulator of G-
protein signaling 17 
 rgs17 ENSDARG00
000039435 
IRBOp991C0
248D 
CNS - eyes CNS - eyes CNS - eyes CNS 
Centb1 /// 
Tnk1 
tyrosine kinase, 
non-receptor, 1 /// 
centaurin, beta 1 
zgc:153917  ENSDARG00
000056346 
IRBOp991C0
380D   
No expression No expression No expression No expression 
Nrxn3  neurexin III nrxn3a  ENSDARG00
000043746 
IRBVp5006G
0715D 
Ubiquitous  Ubiquitous Ubiquitous Ubiquitous 
  nrxn3b  ENSDARG00
000062693 
--- --- --- --- --- 
 
 
Table 7 Selected genes enriched in mouse thyroid bud with FC<10. 
Gene 
symbol 
Gene title Gene 
symbol 
Zebrafish 
ortholog  
Ensembl 
gene  ID  
Zebrafish 
ortholog 
Clone 
availability 
24 - 28 hpf 42 -48 hpf 72 hpf 96 hpf 
Odz4 odd Oz/ten-m 
homolog 4 
(Drosophila) 
odz4 ENSDARG00
000034264 
IMAGp998D
139545Q 
CNS CNS CNS CNS 
  ENSDARG00
000037122 
ENSDARG00
000037122 --- --- --- --- --- 
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  A8E7B2_DA
NRE 
ENSDARG00
000011171 --- --- --- --- --- 
  ENSDARG00
000078358 
ENSDARG00
000078358 --- --- --- --- --- 
Zfp612 zinc finger protein 
612 
       
Bmf Bcl2 modifying 
factor 
bmf2  ENSDARG00
000041414 --- --- --- --- --- 
    bmf1 GeneID: 
571949  
Cloned  Somites - heart- CNS pectoral fins - heart- 
thyroid region 
pectoral fins pectoral fins 
Dock9 dedicator of 
cytokinesis 9 
LOC1001514
88  
ENSDARG00
000016311 
IMAGp998G
2414303Q  
pharyngeal arches - 
ventral somites - 
pronephric ducts - eyes 
- CNS-pancreas 
otic vesicles - thyroid 
region - pancreas 
CNS - eyes - 
heart 
Pharynx 
    DOCK9 (2 of 
2)  
ENSDARG00
000079069 
IMAGp998N
0515229Q  
liver - notochord - 
pharyngeal arches- 
lens - heart 
Heart liver - gut - 
pharyngeal 
arches - heart - 
lens 
Pharynx 
Zfp467 zinc finger protein 
467 
       
Hhip Hedgehog-
interacting protein 
hhip  ENSDARG00
000060397 
IRBOp991C1
183D 
olfactory placodes - 
lens - CNS - tail - 
pectoral fins  
pectoral fins - 
pharyngeal arch 
Pharynx - 
pectoral fins 
Pharynx - 
pectoral fins 
Cxcl12 chemokine (C-X-C 
motif) ligand 12 
cxcl12a  
ENSDARG00
000037116 
IRBOp991G0
372D 
pharyngeal arches - 
notochord - CNS 
pharyngeal region pharyngeal 
region 
pharyngeal 
region 
    cxcl12b  ENSDARG00
000055100 
IRBOp991H0
176D 
pharyngeal arches - 
thyroid region - tail 
somites  
CNS - pharyngeal 
region 
pharyngeal 
region 
pharyngeal 
region 
Sall1 sal-like 1 
(Drosophila) 
sall1b  dxzENSDAR
G00000022
145 
--- --- --- --- --- 
    sall1a  ENSDARG00 IMAGp998P Stamnium corpuscles - Stamnium corpuscles Stamnium CNS - eyes 
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000074144 0815678Q  CNS - rombomers -
neural tube - pectoral 
fin 
- CNS - rombomers - 
neural tube - pectoral 
fin - pronephric duct 
- heart - thyroid 
region 
corpuscles - CNS 
- heart - 
pharyngeal arch 
- eyes 
    LOC1001495
26  
ENSDARG00
000075891 --- --- --- --- --- 
Odz2 odd Oz/ten-m 
homolog 2 
(Drosophila) 
A8E7B2_DA
NRE 
ENSDARG00
000011171 --- --- --- --- --- 
  ENSDARG00
000037122 
ENSDARG00
000037122 --- --- --- --- --- 
Id4 /// 
LOC10004
5546 
inhibitor of DNA 
binding 4 /// similar 
to Id4 
zgc:123214 ENSDARG00
000045131 
IRBOp991A0
872D  
 
CNS (hindbrain) - heart CNS CNS CNS 
Gli2 GLI-Kruppel family 
member GLI2 
gli 2 a ENSDARG00
000025641 
IMAGp998I0
68975Q  
Ubiquitous (high 
levels) 
CNS (nose, 
commissure) 
pharyngeal region 
Pharyngeal 
region 
Pharyngeal 
region 
  gli 2 b ENSDARG00
000020884 
IMAGp998P
0119328Q  
Posterior CNS - blood 
island 
CNS - pharyngeal 
arches 
Pharyngeal 
arches 
Pharyngeal 
arches 
 
 
 
 
 
